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Twin gestations represent 1% to 2% of all pregnancies. Two thirds of twin 
gestations are fraternal or dizygotic twins and one third of twin gestations 
are identical or monozygotic twins. Of live born monozygotic twins, 25-30% 
has completely separate placentas with dichorionic diamniotic membranes, 
whereas 70-75% shares one placenta with monochorionic diamniotic 
membranes. Whether the membranes are monochorionic or dichorionic, and 
vascular anastomoses between both circulations do or do not exists, depends 
on whether cleavage occurred before or after day 3 post-conception.1 Only 
1-2% of live born monozygotic twins share one placenta with monochorionic 
monoamniotic membranes. Monozygotic twins have a significantly higher 
risk of adverse outcome than dizygotic twins (RR 2.5; 95% CI, 1.1-2.5).2 It is 
chorionicity, rather than the zygosity, that determines the adverse outcome. 
Perinatal statistics often underestimate the problem, because the highest fetal 
loss rate occurs before viability. In fact, monochorionic twins have a six fold 
higher fetal loss rate (12%) between 10 and 24 weeks’ gestation compared with 
dichorionic twins and singletons.3
Vascular anastomoses are almost invariably present in monochorionic 
placentas, but not in dichorionic placentas.4 These vascular anastomoses 
are an important cause of morbidity and mortality. Three types of placental 
vascular anastomoses have been documented: the superficial bidirectional 
artery to artery (AA) and vein to vein (VV) anastomoses, and the so-called deep 
unidirectional artery to vein (AV) anastomoses. (Figure 1) 
The major complications of monochorionic twin gestation are twin-to-twin 
transfusion syndrome (TTTS), intra-uterine growth restriction (IUGR), and 
discordant fetal anomalies, e.g. twin reversed arterial perfusion (TRAP). These 
complications are associated with a very high rate of perinatal morbidity 
and mortality. In monochorionic twin pregnancies, the occurrence of single 
intrauterine fetal demise of one twin carries a risk of co-twin demise and 
neurological abnormality in the surviving co-twin of 12% and 18%, respectively, 
compared to 4% and 1% in dichorionic twin pregnancies.5 In case of single 
intrauterine fetal demise in monochorionic twin pregnancies, the vascular 
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anastomoses allow transfer of blood from the surviving twin to the dead 
co-twin, the so-called acute perimortem intertwin transfusion, giving rise to 
periods of hypo perfusion, hypotension and acute fetal anaemia.6 The risk of 
mortality of the healthy co-twin is higher in the presence of superficial AA and 
VV anastomoses than in the presence of only AV and VA anastomoses.7
Twin-to-twin-transfusion syndrome
TTTS only occurs in monochorionic twin pregnancies and is one of the most 
lethal conditions in perinatal medicine. Several forms of TTTS have been 
described: chronic, acute perimortem, acute perinatal and TRAP. Chronic TTTS 
is the most common form, complicating approximately 15% of monochorionic 
diamniotic twin pregnancies, and is the consequence of a chronic imbalance 
Figure 1 Placenta from a monochorionic twin pregnancy without twin-to-twin transfusion 
syndrome after dye-injection (blue for arteries and orange or yellow for veins). The left 
white arrow indicates an arterioarterial anastomose and the right white arrow indicates 
a venovenous anastomose. The black arrow indicates an arteriovenous anastomose from 




in the net blood flow across the vascular anastomoses on the monochorionic 
placenta.8;9 The imbalance occurs when blood flow from one twin through 
unidirectional AV anastomoses is insufficiently compensated by blood flow 
through AV anastomoses in the opposite direction or through bidirectional 
superficial anastomoses (AA and VV). The number, size and type of the vascular 
anastomoses appear to play an important role in the development of TTTS.10 
For the development of TTTS the presence of at least one AV anastomosis 
is essential. The presence of AA anastomoses is thought to offer protection 
against the development of TTTS, which has also been demonstrated in a 
mathematical computer model of chronic TTTS.11-13 Large AA anastomoses 
are also known to be present in the vast majority of monoamniotic twin 
pregnancies and are held responsible for the fact that TTTS develops five times 
less frequently in monoamniotic twins then in diamniotic twins.14;15
Vascular anastomoses are already present in the first trimester, but clinical 
signs occur in the second trimester of pregnancy (14-26 weeks). In general, 
polyhydramnios with or without premature contractions is the first clinical sign 
of TTTS. The first sonographic signs of TTTS are oliguria in the donor, resulting 
in oligohydramnios in the donor sac, and polyuria in the recipient, resulting 
in a polyhydramnios in the recipient sac. Hereafter, more severe signs may 
occur such as anuria in the donor, heart failure and hydrops in the recipient, 
and single or double fetal demise. Polyhydramnios may result in premature 
contractions or preterm rupture of membranes, leading to preterm birth. 
Intertwin growth discrepancy and haemoglobin discordance are often reported, 
bur are not key criteria for the diagnosis of chronic TTTS.16;17 Quintero 
proposed a staging system in order to classify the severity of the syndrome.18 
Stage 1 is the poly/oligohydramnios sequence with a deepest vertical pocket 
of ≥ 8cm before 20 weeks of gestation or ≥ 10cm after 20 weeks of gestation 
in the sac of the recipient and a deepest vertical pocket of ≤ 2 cm in the sac 
of the donor, with the bladder of the donor still visible. In stage 2, the bladder 
of the donor remains empty as the result of anuria. Stage 3 is characterised 
by severely abnormal Doppler measurements: absent or reversed end-diastolic 
flow in the umbilical artery of the donor or abnormal venous Doppler patterns 
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in the recipient, such as reverse flow in the ductus venosus or pulsatile 
umbilical venous flow. In stage 4, the recipient is hydropic and in stage 5 a 
single or double fetal demise has occurred. (Table 1)
Therapeutic options that have been used include expectant management, 
empiric medical treatment (e.g. digoxin), septostomy, selective feticide, serial 
amnioreduction and laser coagulation of vascular anastomoses. In severe TTTS, 
conservative treatment is associated with mortality rates of more than 80%, 
although more recently an overall survival rate of 37% was reported.19-21 
Medical treatment with maternal digoxin administration to improve cardiac 
function in the recipient, although anecdotically associated with success, and 
indomethacin therapy to reduce polyhydramnios have not been proven to be of 
benefit.22;23 Septostomy, the intentional puncturing of the intertwin membrane, 
has not proven to be a superior treatment option in previable TTTS. The only 
advantage of septostomy over serial amnioreduction, was that there were 
less invasive procedures in the septostomy group.24 In addition, results of a 
study with a mathematical model for chronic TTTS suggest that septostomy is 
unlikely to offer significant therapeutic efficacy.25
Table 1 Staging classification of chronic TTTS according to Quintero18
Stage Sonographic criteria
stage 1 combination of polyhydramnios* and oligohydramnios**
stage 2 bladder of the donor twin not visible
stage 3 critically abnormal Doppler studies†
stage 4 ascites, pericardial or pleural effusion, scalp oedema, or overt hydrops are present
stage 5 single or double fetal demise
* deepest vertical pocket of amniotic fluid ≥ 8 cm (below 20 weeks) or ≥10 cm (above 20 
weeks)
** deepest vertical pocket ≤ 2 cm
† reversed flow in the ductus venosus or pulsatile umbilical venous flow in the recipient, 




Selective feticide by occlusion of the umbilical cord through ligation or 
bipolar coagulation in order to save one infant and optimise its prognosis can 
be a treatment modality in selected cases, for example in the case of poor 
prognosis of one fetus.26 Serial amnioreduction is a symptomatic treatment for 
TTTS and involves the repetitive removal of large volumes of amniotic fluid. 
It has been used since the 1980s. The transient reduction of amniotic fluid 
reduces pressure on the placenta with improvement of transplacental fluid 
flow between mother and foetus, and reduces the risk of preterm delivery.25 
The overall perinatal survival rate in uncontrolled published series with cases 
diagnosed before 26 weeks was approximately 60% with a risk of severe 
neurological sequelae in 16% of survivors.21;27
Fetoscopic laser coagulation of vascular anastomoses on the placental surface, 
a cause-oriented approach for TTTS, was developed in the United States and 
the United Kingdom and first described by De Lia et al in 1990.28-30 After 
fetoscopic coagulation of the anastomotic vessels, the polyhydramnios in the 
sac of the recipient is drained. The reported overall perinatal survival rates in 
case series treated with fetoscopic laser coagulation vary from 48 to 71%.18;28-38
The technique of laser coagulation has been adapted over the years. The 
earlier described technique of coagulating all vessels crossing the intertwin 
membrane is no longer first choice treatment, because it leads to unnecessary 
placental loss.30 Although the theoretical concept of coagulating only the 
causative AV anastomoses has been discussed, most groups do adhere to 
an approach of selectively coagulating all visualised anastomoses.39;40 A 
recent randomised trial reported significantly higher perinatal survival and 
improved neurological outcome in TTTS survivors after fetoscopic laser surgery 
compared to serial amnioreduction.41 The overall survival in the laser group 
compared to the amnioreduction group was 57% versus 41%, respectively 
(p=0.01). Survival of at least one twin at the age of six months was 76% in the 
laser group and 51% in the amnioreduction group (p=0.002). At the age of 
six months, major neurological sequelae were found in 19% of the surviving 
children after amnioreduction and in 7% after laser surgery (p=0.05). Long-
term neurodevelopmental outcome of the surviving children has not yet been 
reported.41
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Early complications occurring in the first week after fetoscopic laser surgery 
include miscarriage (12% of cases), premature rupture of membranes (7%), 
placental abruption (1.7%), and intrauterine fetal death (13% to 33%) and double 
intrauterine fetal death (3% to 22%).42;43 Late complications include preterm 
premature rupture of membranes before 32 weeks (17%), recurrence of TTTS 
(14%), isolated marked discordant haemoglobin levels (13%), and double 
intrauterine fetal demise (1% of cases).43
Whether fetoscopic laser coagulation is the treatment modality of choice 
in all stages of chronic TTTS is still unclear. Some authors suggest a stage-
based treatment of chronic TTTS, with amnioreduction in milder cases of 
TTTS and laser surgery in the more advanced stages of TTTS.44 However, the 
randomised study of Senat et al showed significant better outcome in the laser 
surgery group compared to the amnioreduction group in all stages.41 Another 
prospective study showed a significant trend towards reduced survival rates 
with increasing stage (p=0.038) and concludes that fetoscopic laser surgery is 
an effective therapeutic option for all stages of TTTS.45 
Discordant growth retardation in monochorionic twins
The proportion of pregnancies with a birth weight discordance of more than 
25% is similar in monochorionic and dichorionic twin pregnancies, 11 and 12% 
respectively. However, the proportion of pregnancies with one fetus with a 
birth weight below the 10th percentile is significantly higher in monochorionic 
than in dichorionic twin pregnancies, 53% and 37% respectively.3 With a birth 
weight discordance of more than 25%, the smaller twin will have a birth weight 
below the 10th percentile in 62% of pregnancies.46 The differential diagnosis 
between TTTS en discordant intrauterine growth retardation in monochorionic 
twins can easily be made by the absence of polyhydramnios in the sac of the 
appropriately grown fetus. Birth weight discordance carries a greater risk 
in monochorionic compared to dichorionic twin pregnancies because of the 
vascular anastomoses on the placental surface. Intrauterine fetal demise of 




resulting in neurological damage or death of the co-twin.6 Management options 
in discordant growth retardation include expectant management, selective 
feticide of the severely growth retarded twin through cord coagulation, 
fetoscopic laser coagulation of vascular anastomoses to convert to a 
dichorionic twin pregnancy or elective delivery. The best way of management in 
these complex situations is not yet clear.
Discordant structural anomalies in monochorionic twins
Structural anomalies are more common in twins than in singletons. The 
frequency of malformations in dizygotic twins is thought to be similar to that 
of singletons (2-3%), while it has been reported to be two to three times higher 
in monozygotic twins. However, the true incidence is difficult to assess since 
most studies failed to determine zygosity, and some assumed dizygosity in 
the presence of a discordant anomaly.47 Anomalies include malformations 
like conjoined twins, acardiac twins, neural tube defects, brain defects, facial 
clefts, cloacal and abdominal wall anomalies.48 Structural heart malformations 
in monochorionic twins without TTTS are four times more common than in the 
general population.49 Overall, it has been estimated that in approximately 15% 
of cases only one twin is affected.50 Although monozygotic twins are thought 
to be genetically identical, a number of discordances for common chromosomal 
anomalies have been noted.51 The most frequently reported heterokaryotypia is 
the discordance for Turner syndrome.52 The major risk of a discordant anomaly 
in a monochorionic twin is single intrauterine fetal demise of the affected twin 
with acute perimortem intertwin transfusion.
Management options for discordant anomaly in monochorionic twin pregnancy 
include expectant management, selective feticide or pregnancy termination. 
The presence of vascular anastomoses does not allow the injection of any 
lethal agent to achieve selective feticide in monochorionic twin pregnancies. 
The injected drug may leak into the unaffected twin’s circulation causing 
direct death, or may lead to acute perimortem intertwin transfusion from the 
healthy co-twin into the dying fetus and result in intrauterine fetal death or 
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organ damage in this co-twin.53 In monochorionic twin pregnancies, selective 
termination needs to be performed by ensuring complete and permanent 
occlusion of both the arterial and venous flows in the umbilical cord of the 
affected twin, in order to avoid acute perimortem intertwin transfusion from 
the co-twin into the dying twin. Several techniques have been described to 
interrupt the blood flow in the umbilical cord including embolisation of the 
umbilical cord using sclerosant agents, fetoscopic umbilical cord ligation, 
fetoscopic laser coagulation of the umbilical cord and sonographically guided 
bipolar coagulation of the umbilical cord.54-57 On the basis of current data, it 
seems best to consider fetoscopically guided laser coagulation of the cord up 
to 20 weeks’ gestation.58 After 20 weeks, the thickness of the cord and the 
quantity of Wharton’s jelly content limit the effects of laser, and in these cases 
bipolar coagulation is probably more successful.59
Outline of the thesis
Leiden University Medical Centre (LUMC) is a tertiary medical centre in the 
Netherlands and serves as the national referral centre for fetal therapy. The 
fetoscopic surgery program started in August 2000. Since then, several study 
projects associated with the fetal surgery program were initiated, with an 
ongoing collaboration between the obstetric and neonatology departments of 
the LUMC. The studies in this thesis can be summarised as follows:
Chapter 2 - Study to assess the value of serial ultrasound examinations 
together with patient instructions in achieving timely detection of TTTS in 
a cohort of monochorionic diamniotic twin pregnancies, and to evaluate 
sonographic TTTS predictors. 
Chapter 3 - Study on the initial results of fetoscopic laser surgery for severe 
second trimester TTTS treated at the LUMC and on the relation between 




Chapter 4 – Study on the frequency of residual placental vascular anastomoses 
after fetoscopic laser surgery for TTTS and their relation to complications and 
outcome.
Chapter 5 – Study on the technical result and perinatal survival of a novel 
technique, developed at the LUMC. Laparoscopy is used to guide safe 
percutaneous insertion of the fetoscope through the lateral abdominal wall 
and the dorsal side of the uterus to allow fetoscopy in TTTS with completely 
anterior placenta.
Chapter 6 – Study on the long-term neurodevelopmental outcome in TTTS 
treated with fetoscopic laser surgery at the LUMC between August 2000 and 
December 2003.
Chapter 7 – Description of technical details of selective feticide and outcome 
of three monoamniotic twin pregnancies, discordant for fetal anomaly (two 
cases of anencephaly and one case of congenital heart block), in which cord 
occlusion was followed by transection of the cord, using contact laser.
Chapter 8 – Study on the outcome in TTTS, diagnosed after 26 weeks’ 
gestation. Cases treated with fetoscopic laser surgery were compared to a 
control group, treated with amniodrainage.
Chapter 9 – Summary of the acquainted knowledge, general discussion 
concerning the results of the studies and proposals for future research. 
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Abstract 
Objective: To assess the value of serial ultrasound examinations together 
with patient instructions to report the onset of symptoms in achieving 
timely detection of twin-to-twin transfusion syndrome (TTTS) in a cohort of 
monochorionic diamniotic twin pregnancies, and to evaluate sonographic TTTS 
predictors.  
Methods: Timely detection of TTTS was defined as diagnosis before severe 
complications of TTTS occurred, such as preterm prelabour rupture of 
membranes, very preterm delivery (24-32 weeks of pregnancy), fetal hydrops, 
or intrauterine fetal death. During a 2-year period, a prospective series of 
23 monochorionic twin pregnancies was monitored from the first trimester 
until delivery. At least every 2 weeks we performed ultrasound and Doppler 
measurements (nuchal translucency thickness, presence of membrane folding, 
estimated fetal weight, deepest vertical pocket, bladder filling, and Doppler 
waveforms of the umbilical artery, ductus venosus, and umbilical vein).
Measurements of TTTS cases were compared with those of non-TTTS cases 
matched for gestational age. Furthermore, patients were informed about the 
symptoms caused by TTTS, and instructed to consult us immediately in case of 
rapidly increasing abdominal size or premature contractions.
Results: In all four TTTS cases, the diagnosis was timely. At the time of 
diagnosis, one case was at Quintero Stage 1, two at Quintero Stage 2, and one 
at Quintero Stage 3.Two of the TTTS cases became apparent after the patients’ 
feeling of rapidly increasing girth. The identification of TTTS predictors was 
successful with respect to one parameter: isolated polyhydramnios in one sac, 
without oligohydramnios in the other, preceded the ultimate diagnosis of TTTS 
in two of the four TTTS cases. All other ultrasound measurements of TTTS 
cases, prior to the diagnosis of TTTS, were within the range of measurements 
of non-TTTS cases.
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Conclusions: Biweekly ultrasound examinations, with special attention to 
amniotic fluid compartments of both fetuses, combined with detailed patient 
instructions to report the onset of symptoms resulted in timely diagnosis of all 
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Introduction
Twin-to-twin transfusion syndrome (TTTS) occurs in 15% of monochorionic 
diamniotic twin pregnancies.1 The syndrome is caused, at least partly, by 
unbalanced blood flow through vascular placental anastomoses between 
the twin fetuses, and presents sonographically as an oligo/polyhydramnios 
sequence. TTTS has been classified into five stages according to Quintero et 
al.2 Untreated, it is associated with extremely high mortality and morbidity 
rates.3-6 In a recent randomised comparison with serial amniodrainage, 
treatment by fetoscopic laser coagulation of the placental vascular 
anastomoses was associated with higher perinatal survival rates, more 
advanced gestational age at delivery and better neurological outcome.7 
Moreover, perinatal survival rates after laser therapy were higher in TTTS stage 
1 or 2 than in stage 3 or 4.7;8 Increasingly, therefore, attention is being paid to 
the timely diagnosis and treatment of TTTS. 
Several studies have focused on the identification of sonographic markers that 
could forecast the development of TTTS. Sebire et al found that pregnancies 
with increased nuchal translucency thickness in the first trimester and folding 
of the intertwin membrane in the second trimester are at increased risk of 
developing TTTS.1;9;10 Also, the presence of a velamentous umbilical cord 
insertion and sonographic absence of arterioarterial anastomoses have been 
found to be more common in pregnancies with TTTS.11;12 The observation 
of such TTTS predictors could thus lead to increased surveillance during the 
pregnancy and hence to the timely detection of TTTS. Absence of these factors, 
however, does not guarantee that TTTS will not develop. 
Symptoms and staging of TTTS are clearly defined, which makes the syndrome, 
if present, easy to diagnose.2 Little is known, though, about the optimal 
surveillance strategy of monochorionic twins in order to detect TTTS before 
severe complications occur. The first objective of this prospective study 
was to assess the value of biweekly ultrasound examinations together with 
patient instructions to report the onset of symptoms in achieving timely 
detection of TTTS in a cohort of monochorionic diamniotic twin pregnancies. 
Timely detection was defined as diagnosis before the occurrence of severe 
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complications of TTTS. Patients were instructed to consult us if they had the 
impression of rapidly increasing abdominal girth or premature contractions, 
in which case an ultrasound examination was performed within 24 hours. 
The second objective of this study was to assess the prognostic value of 
nuchal translucency thickness, folding of the intertwin membrane, estimated 
fetal weight (EFW) and ultrasound markers used for Quintero-staging in the 
development of TTTS (TTTS-predictors). 
Methods
We performed a longitudinal, prospective study of all monochorionic diamniotic 
twin pregnancies referred to our obstetrical unit during a 2-year period 
(September 2002 - September 2004). Inclusion criteria were: gestational 
age below 16 completed weeks and no signs of TTTS at initial ultrasound 
examination, an absent lambda sign and thin dividing membrane on ultrasound 
(considered to be evidence of monochorionic diamniotic twinning), and 
absence of fetal abnormalities. In all cases, gestational age was based on the 
first day of last menstrual period and confirmed by ultrasound examination in 
the first or early second trimester. Placental pathological examination was used 
to confirm monochorionicity after birth.
The study involved serial abdominal ultrasound and Doppler examinations, 
carried out at least every 2 weeks from when the twin pregnancy was first 
discovered until delivery. In cases of abnormal ultrasound findings that raised 
the suspicion of future development of TTTS, the examination frequency was 
increased. Ultrasound examinations were performed by one of two experienced 
sonographers. Nuchal translucency thickness was measured only once in 
the first trimester in cases presenting before 14 weeks, and the following 
parameters were measured at each examination: folding of the intertwin 
membrane; EFW; deepest vertical pocket (DVP) of amniotic fluid for each fetus; 
bladder filling (viewed three times with 10-min intervals and classified as 
normal, collapsed or enlarged); end-diastolic flow (EDF) of the umbilical artery 
(UA) (recorded as present, absent or reversed); A-wave in the ductus venosus 
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(DV) (recorded as present, absent or reversed); flow pattern of the intrahepatic 
part of the umbilical vein (UV) (classified as pulsatile or non-pulsatile). All 
measurements were performed in the absence of fetal movements using an 
Acuson Sequoia (Acuson, Mountain View, California, USA) ultrasound machine 
with a 4.0- or 6.0-MHz-probe. 
TTTS was diagnosed by the presence of oligo/polyhydramnios sequence in the 
absence of other causes. Polyhydramnios and oligohydramnios were defined 
as a DVP of amniotic fluid of >8 cm at ≤20 weeks (or >10 cm at >20 weeks) 
and <2 cm, respectively. TTTS severity was assessed based on Quintero’s 
established criteria2: Stage 1, isolated oligo/polyhydramnios sequence; Stage 
2, absent visible bladder of the donor twin; Stage 3, critically abnormal Doppler 
results (absent/reversed EDF of the UA, absent/reversal of flow during atrial 
contraction in DV, or pulsatile flow pattern of the intra-hepatic part of the UV); 
Stage 4, hydrops in either fetus; Stage 5, demise of one or both twins. Timely 
detection of TTTS was defined as diagnosis before the occurrence of severe 
complications of TTTS, such as preterm prelabour rupture of membranes, very 
preterm delivery (24-32 weeks of pregnancy), fetal hydrops, or intrauterine 
fetal death. TTTS diagnosed <26 weeks was treated by fetoscopic laser 
coagulation of communicating placental vessels. This was always combined 
with a single amniodrainage procedure. TTTS diagnosed >26 weeks was treated 
by (repeated) amniodrainage procedure(s). Additionally, patients were informed 
about the symptoms caused by TTTS and were instructed to consult us 
immediately in the case of rapidly increasing girth or premature contractions. 
In this case, sonography was performed as soon as possible (within 24 hours). 
The institutional review board approved this study and all patients gave 
informed consent. Pregnancies affected by TTTS were referred to as “TTTS 
cases”, and those not complicated by TTTS were referred to as “non-TTTS 
cases”. In order to identify TTTS predictors, sonographic measurements of 
TTTS cases were compared with the mean value of non-TTTS cases matched 
for gestational age. The range of values obtained from non-TTTS cases 
was considered to be normal. Values of TTTS cases outside this range were 
considered abnormal. 
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Results
During the 2-year period, 25 consecutive monochorionic diamniotic twin 
pregnancies were managed prospectively at our hospital. One pregnancy was 
excluded from the study because of fetal malformation (lower urinary tract 
obstruction) followed by selective feticide by cord coagulation. One patient 
refused to participate in the study because of concerns about the safety of 
frequent scanning. The remaining 23 patients were included. In total, 268 
Table 1 Pregnancy characteristics for cases with and without twin-to-twin transfusion 
syndrome (TTTS) 
Characteristic




   
Maternal age (years, median (range)) 35.0 (33-40) 34.0 (23-39)
   
Parity (median (range)) 4 (1-5) 2 (1-4)
   
Gestational age (weeks, median (range) at:   
-          initial US examination 12.6 (11.3-14.6) 12.3 (11.0-15.6)
-          TTTS diagnosis 23.4 (16.9-29.1) -
-          delivery 32.2 (18.3-37.0) 36.1 (19.1-38.7)
   
Pregnancies (n (%)) with:   
-          double perinatal survival 3 (75%) 18 (95%)
-          single perinatal survival 0 ( 0%)  0 ( 0%)
-          no perinatal survival 1 (25%)*  1 ( 5%)†
   
*TTTS treated with uncomplicated laser therapy at 16+6 weeks. At 17+6 weeks’ gestation, 
abrupt double intrauterine death was diagnosed. Autopsy was refused. †Sudden double 
intrauterine death at 19 weeks. At autopsy, one of the fetuses was found to have a 
frontonasal malformation and left cardiac ventricular hypertrophy with abnormal 
pulmonary venous return. The other twin was unaffected. US, ultrasound.
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ultrasound examinations of 23 twin pairs were performed. Median number of 
ultrasound examinations per patient was 12 (range, 4-17). 
Four pregnancies (17%) were complicated by TTTS and were diagnosed before 
the occurrence of severe complications. They were treated by either fetoscopic 
laser coagulation (n=2), amniodrainage prior to laser therapy 4 weeks later 
(n=1), or amniodrainage alone (n=1). Two of these four TTTS-cases became 
apparent after the patient experienced rapidly increasing girth, which made 
them ask for an extra scan between regular visits. None of the 19 patients 
without TTTS presented between regular visits with similar complaints. Clinical 
details of TTTS cases and non-TTTS-cases are given in table 1. All ultrasound 
findings prior to the diagnosis of TTTS in the four TTTS-cases are given in table 
2.
Nuchal translucency thickness >95th centile in at least one of the fetuses was 
found in 2/16 pregnancies (13%).13 None of these pregnancies was complicated 
by TTTS. Folding of the intertwin membrane was seen at least once in six 
pregnancies (26%), of which one developed TTTS. One other pregnancy with 
membrane folding had large discrepancies in amniotic fluid 
 (polyhydramnios without oligohydramnios and without other signs suggestive 
of TTTS) and fetal size that persisted until delivery but did not require any 
form of treatment.The other 4 cases with membrane folding had an uneventful 
course. Isolated polyhydramnios without further signs of TTTS was diagnosed 
in three (13%) pregnancies, of which two went on to develop TTTS. The third 
pregnancy with polyhydramnios in one sac (maximum DVP, 15.8 cm) was the 
one mentioned above with intertwin membrane folding that did not develop 
other signs of TTTS during pregnancy. Prior to the diagnosis of TTTS, TTTS and 
non-TTTS cases did not differ in: EFW, bladder filling, EDF of the UA, A-wave of 
the DV, and pulsations of the UV. 
The first TTTS case had 2 normal ultrasound examinations until diagnosis of 
TTTS at 16+6 weeks. At this time, during a routine visit, oligo/polyhydramnios 
sequence was observed, with a DVP of 1.0 cm and 7.3 cm for donor and 
recipient, respectively. Also, the donor’s bladder was collapsed and the 
recipient’s bladder was enlarged. The flow in the UV was pulsatile. Despite 
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the DVP of the recipient being <8 cm, the combination of a collapsed and 
an enlarged bladder together with a critically abnormal Doppler suggested a 
TTTS Quintero Stage 3. Treatment by laser coagulation of the communicating 
placental vessels (three arteriovenous anastomoses from donor to recipient) 
was performed. There were no complications during the procedure. However, 
at 17+6 weeks’ gestation, 1 week after treatment, an abrupt double 
intrauterine fetal death was diagnosed.
In the second case, TTTS was diagnosed at 22+1 weeks. All five previous 
ultrasound examinations had been unremarkable. At the regular, biweekly 
scan at 22+1 weeks’ gestation, the DVP of Twin A and Twin B measured 
3.7 and 11 cm, respectively. Throughout the 45-min examination, Twin A 
showed a collapsed bladder and Twin B had normal bladder filling. Doppler 
measurements were normal. Despite the donor’s DVP measuring >2 cm, 
we considered this case (due to the absence of bladder filling in the donor 
twin) to be Quintero Stage 2. Treatment with fetoscopic laser coagulation 
of communicating placental vessels was performed (three arteriovenous 
anastomoses from donor to recipient and 1 arteriovenous anastomosis from 
recipient to donor). Spontaneous delivery occurred at 31+5 weeks.  
In the third case the first ultrasound examination was at 14+4 weeks’ 
gestation, too late for appropriate nuchal translucency thickness measurement. 
The first two scans, at 14+4 and 17+0 weeks, showed normal values for 
both fetuses. Ultrasound examination at 19+2 weeks revealed one of the 
twins to have a DVP of 9.1 cm, which increased to 11.2 cm at 19+4 weeks. 
There was, however, no oligohydramnios in the other sac (DVP, 3.8 and 4.7 
cm, respectively) and bladder filling and Doppler measurements were within 
normal ranges for both fetuses. There were no fetal anomalies explaining the 
increase in amniotic fluid. At 20+3 weeks, effacement of the cervix prompted 
amniodrainage of 1100 mL and placement of a cerclage. In the next weeks, 
the recipient twin’s DVP increased from 6.5 to 11.9 cm, whereas the donor 
twin did not develop oligohydramnios. The bladder filling and Doppler 
studies of both fetuses remained normal. At 24+5 weeks, 3 days after the 
last ultrasound examination, the woman contacted us with complaints of 
abdominal distension. At this time, a fetus with polyhydramnios (DVP, 13.5 cm) 
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and enlarged bladder was seen in one sac; while in the other sac a stuck twin 
with oligohydramnios (DVP, 0.5 cm) and normal bladder filling was identified 
(Quintero Stage 1). Laser coagulation of the communicating placental vessels 
(four arteriovenous anastomoses from donor to recipient) was performed. At 
37+0 weeks, labour was induced. 
The fourth case was diagnosed at 29+1 weeks. The four ultrasound scans 
obtained between 11+2 and 17+1 weeks of gestation were uneventful. At the 
next six weekly ultrasound examinations, between 18+1 and 24+1 weeks’ 
gestation, we observed folding of the intertwin membrane. Other sonographic 
measurements were unremarkable. The patient came to the hospital between 
regular visits at 29+1 weeks, one week after the last examination, because 
of rapidly increasing abdominal size. On ultrasound examination, a stuck 
twin with oligohydramnios (DVP, 0.8 cm) and collapsed bladder was noted. 
The recipient twin had polyhydramnios (DVP, 14.0 cm) with an enlarged 
bladder. Doppler measurements were all normal. A diagnosis of TTTS Quintero 
Stage 2 was made. Previous ultrasound examinations had already shown an 
accumulation of amniotic fluid in the recipient’s sac (DVP measuring 10.2 cm 
and 11.7 cm at 26+1 and 28+1 weeks). The amniotic fluid compartment of 
the donor twin, however, had remained within normal ranges during these 
previous examinations (5.6 cm at 26+1 and 7.7 cm at 28+1 weeks). Because 
the gestational age was >26 weeks, this patient was treated by repeated 
amniodrainage. She delivered spontaneously at 32+4 weeks. 
The fetal loss rate was 25% (2/8) for TTTS cases and 5% (2/38) for non-TTTS 
cases (Table 1). All 42 fetuses that were born alive were structurally normal. 
At autopsy, one of the demised fetuses of the non-TTTS group was found to 
have a frontonasal malformation and left cardiac ventricle hypertrophy with 
abnormal venous pulmonary return. Its demised co-twin was unaffected. For 
the two fetuses that died after laser therapy, the parents refused autopsy. 
Monochorionicity of all placentas was confirmed histological. 
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Discussion
Our study evaluated prospectively the natural history of monochorionic 
diamniotic twin pairs with regard to the development of TTTS during fetal life. 
We succeeded in the timely diagnosis of TTTS cases by a program of frequent 
(biweekly) ultrasound examinations and patient instructions to report the 
onset of symptoms, diagnosing all TTTS cases before severe complications of 
TTTS were encountered: there were no cases of preterm prelabour rupture of 
membranes or very preterm deliveries caused by polyhydramnios, and no cases 
of fetal hydrops or fetal death. Patient instructions turned out to be highly 
relevant for the timely detection of TTTS; two of the four TTTS cases in our 
series became apparent the patient experienced rapidly increasing girth. None 
of the 19 patients without TTTS presented between their regular scheduled 
visits with similar complaints. Despite the anxiety during pregnancy that may 
be associated with patients being informed extensively on all the risks that 
may be involved with monochorionic twinning, we consider explicit patient 
instructions to be crucial for the timely detection of TTTS.
We identified the DVP of amniotic fluid was identified as being a TTTS 
predictor. In two of the four TTTS cases we found isolated polyhydramnios in 
one sac, without oligohydramnios in the other and with normal bladder filling 
of both fetuses, preceding the ultimate diagnosis of TTTS. Another pregnancy 
with polyhydramnios that lacked coexistence of oligohydramnios, however, 
did not develop TTTS. Polyhydramnios alone must certainly be considered an 
important sign, possibly indicative of the future development of TTTS, but it 
should not invariably lead to invasive treatment. We think it is very importance 
to locate the intertwin membrane and to measure the DVP of each fetus 
routinely at least every 2 weeks. Accumulation of amniotic fluid should alert 
obstetricians and lead to increased sonographic surveillance. 
None of the other sonographic parameters was found to showed to be 
predictive of future TTTS.  As polyhydramnios in TTTS is thought to originate 
mainly from excessive urine production of the recipient twin, it could be 
hypothesized that urinary bladder filling should also be increased. However, 
prior to diagnosis of TTTS, no differences in fetal bladder size between future 
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donor and recipient twins were detected in this study. It would be interesting to 
investigate more extensively whether a discrepancy in fetal urinary production 
precedes the development of an oligo/polyhydramnios sequence. To explore 
this properly, a more detailed approach is required.14
Although EFW differences have long been abandoned in diagnosing TTTS, there 
still exists a general belief that donor twins should be smaller than recipients. 
Formerly, a growth discordance of ≥20% has been used as a diagnostic criterion 
of TTTS. Such a birth weight difference, however, is seen as frequently in 
monochorionic as in dichorionic twins.15 Consequently, a difference in EFW is 
not considered a mandatory feature of TTTS. Similarly, the Quintero staging 
system criteria do not include fetal biometry.2 Differences in EFW are thus not 
expected to be of any help in forecasting TTTS. This was demonstrated in our 
study by the EFW of the donor twin exceeding that of the recipient twin in three 
of the four TTTS cases. 
As stated in Quintero et al’s criteria, the more advanced stages of TTTS are 
characterized by critically abnormal Doppler studies of the UA, DV or UV.2 
Assuming that TTTS is the result of long-lasting circulatory imbalance and 
not a sudden incident, Doppler studies could be expected to deteriorate 
progressively in the weeks before TTTS is diagnosed. However, in our study we 
were unable to show differences between TTTS cases and non-TTTS cases in 
Doppler studies performed prior to the scan revealing TTTS. 
We could not confirm findings of previous studies in which ultrasound markers 
such as nuchal translucency thickness and folding of the intertwin membrane 
were associated with the development of TTTS. Sebire et al suggested that the 
likelihood ratio of an increased fetal nuchal translucency for the prediction 
of TTTS was 3.5.1 Although we found an increased nuchal translucency 
thickness in at least one fetus in 2/16 pregnancies (13%), which is similar to 
the frequency in Sebire’s series, all four cases that later developed TTTS had 
normal nuchal translucency thickness values. Another association found by 
Sebire et al was the occurrence of folding of the intertwin membrane with 
subsequent development of TTTS.10 In their study, folding occurred in 28% 
of monochorionic twin pregnancies and resulted in TTTS in 52% of the cases. 
We found a similar rate (26%) of folding of the intertwin membrane, but only 
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one of these six pregnancies (17%) was subsequently complicated by TTTS. 
Interestingly, 3/17 patients without intertwin membrane folding also developed 
TTTS. Matias et al proposed a role for the combination of increased nuchal 
translucency thickness and abnormal DV flow patterns in anticipating TTTS.16 
This could not be established in our study, since none of the fetuses showed 
absent or reversed flow of the DV during atrial contraction. 
We realise that our study population was relatively small, which may well 
be the reason for our not confirming findings of larger studies. Our study, 
though, was unique for its prospective, longitudinal approach. The rarity of 
monochorionic twinning hampers prospective research in this area. A series of 
23 patients may seem rather undersized, but should be considered relatively 
large in this context. Moreover, we think our study population is representative 
of a normal monochorionic diamniotic twin cohort. The 17% incidence of TTTS 
in our series is comparable with the reported 15%.1 Another potential weakness 
was the lack of a control group, which leads us to refrains from drawing 
conclusions about the advantages of a monitoring program. Nevertheless, 
information on how to manage monochorionic twins is urgently needed and we 
think our study contributes realistic data to this information gap.
In conclusion, based on our study results, we think combined use of 
sonography and maternal symptom monitoring forms a safe program for 
monitoring monochorionic twin pregnancies. Hence, for the timely diagnosis of 
TTTS cases, we advise biweekly ultrasound examinations, with special attention 
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Abstract
Objective:  In this prospective cohort study we evaluated the initial results of 
fetoscopic laser surgery for severe second trimester twin-to-twin transfusion 
syndrome (TTTS) treated at our centre. 
Methods:  A total of 100 consecutive pregnancies with severe second trimester 
TTTS treated at our centre with selective fetoscopic laser coagulation of 
vascular anastomoses on the placental surface between August 2000 and 
November 2004 were included in the study. Perinatal survival was analysed in 
relation to Quintero stage.
Results: Median gestational age was 20 weeks at fetoscopy (range 16-26) and 
33 weeks at delivery (range 18-40). Perinatal survival rate was 70% (139/200). 
The treatment resulted in at least one survivor at the age of 4 weeks in 81% 
of pregnancies. Perinatal survival was significantly higher when treatment was 
performed in the early Quintero stages (95% in stage 1, 76% in stage 2, 70% in 
stage 3, 50% in stage 4) (p=0.02).
Conclusions: Results of fetoscopic laser surgery for TTTS in our centre are 
similar to those in specialised centres in other countries. Diagnosis and 
treatment in the early Quintero stages resulted in significantly higher perinatal 
survival.
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Introduction
Monochorionic twin pregnancies are at risk for developing twin-to-twin 
transfusion syndrome (TTTS) due to unbalanced inter-twin blood-flow through 
placental vascular anastomoses. TTTS may occur in 10-15% of monochorionic 
twin pregnancies, mostly in the second trimester of pregnancy.1 The 
first sonographic signs of TTTS are oliguria in the donor, resulting in 
oligohydramnios in the donor sac, and polyuria in the recipient, resulting 
in a polyhydramnios in the recipient sac. Hereafter, more severe signs may 
occur such as anuria, heart failure, hydrops and single or double fetal demise. 
Premature contractions or preterm rupture of membranes, leading to preterm 
birth, may result from the polyhydramnios. Quintero proposed a staging 
system to classify the severity of the syndrome.2
Until recently, it was unclear which treatment modality provided the best result 
in TTTS. Serial amnioreduction is a symptomatic treatment for TTTS that has 
been used for more than two decades. The transient reduction of amniotic 
fluid reduces pressure on the placenta with improvement of transplacental 
fluid flow between mother and fetus, and reduces the risk of preterm 
delivery.3 More recently, a cause-oriented approach for TTTS was developed 
in the United States and the United Kingdom: fetoscopic laser coagulation of 
vascular anastomoses on the placental surface.4-6 A recent randomised trial 
reported significantly higher perinatal survival and improved neurological 
outcome in TTTS survivors after fetoscopic laser surgery compared to serial 
amnioreduction.7
 
The number of TTTS pregnancies in the Netherlands, with 200,000 births 
annually, is estimated to be 60-90 per year. At Leiden University Medical 
Centre, the national referral centre for invasive fetal therapy, fetoscopic laser 
surgery has been the preferred treatment modality since August 2000. We 
report the perinatal outcome after fetoscopic laser surgery of a consecutive 
series of 100 pregnancies complicated by severe second trimester TTTS.
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Methods
Inclusion criteria for fetoscopic laser surgery were: monochorionic twin 
pregnancy, gestational age between 16 and 26 weeks, not in labour, no 
congenital malformations, TTTS Quintero stage 1 with severe clinical 
symptoms of polyhydramnios, or TTTS Quintero stage ≥ 2. Before fetoscopy, 
detailed sonographic evaluation was performed to exclude congenital 
anomalies, to confirm the diagnosis of TTTS, and to determine the Quintero 
stage. The sonographic investigation included: fetal anatomy and biometry, 
deepest vertical pocket of amniotic fluid of each fetus, bladder filling, arterial 
and venous Doppler studies, placental location, location of umbilical cord 
insertions, and cervical length. On the basis of these findings, an estimation 
of the location of the vascular equator and the optimal insertion site of the 
fetoscope in the uterine wall was made. In the majority of cases, fetoscopic 
laser surgery was performed under regional anaesthesia, but in some cases 
with anterior placenta general anaesthesia was used. A prophylactic dose of 
tocolytics (indomethacin) and antibiotics (amoxycillin/clavulanate) was given 
routinely. In 85 women, the 2 mm semi rigid fetoscope (Storz, Vianen, the 
Netherlands) was introduced percutaneously in the sac of the recipient through 
a straight or curved (up to 40 degrees) shaft with an outer diameter of 3.3 
mm. In 8 cases with an anterior placenta a small (3-5 cm) laparotomy was 
performed in the lateral abdominal wall near the mid-axillary line, between 
the lower ribs and the iliac crest. After opening the peritoneum, bowels were 
moved aside with gauze and the lateral uterine vessels were identified. The 
shaft was then inserted through the posterior uterine wall in order to obtain 
a perpendicular angle between the fetoscope and the vascular equator. In 7 
women, introduction of the shaft in the posterior uterine wall was assisted by 
open entry laparoscopy instead of mini laparotomy. After introduction of the 
fetoscope, vessels crossing the inter-twin membrane were followed to identify 
the anastomotic vessels in the recipient’s sac. When it could be confirmed 
that these crossing vessels belonged to just one twin, they were left intact. 
All vessels that connected to vessels of the other twin were coagulated by 
laser light (diode laser (Diomed Limited, Cambridge, UK) or ND:YAG laser 
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(Dornier Medizin Technik, Germering, Germany)). Isolated arteries and veins, 
coming from the recipient and crossing the inter-win membrane, that could 
not be followed any further, were also coagulated.7;8 Finally, amniotic fluid 
was drained until the deepest vertical pool was less than 6 cm. During the 
procedure, fetal condition was evaluated continuously by ultrasound.
 
Percentage of fetal survival was defined as 100 x number of live born 
children/2 x number of pregnancies. Percentage of perinatal survival 
was defined as 100 x number of children alive at 4 weeks/2 x number of 
pregnancies. Differences in outcome between Quintero stages were analysed 
with Chi square test (linear by linear association). A p-value < 0.05 was 
considered to indicate a statistical significance. Statistical analysis was 
performed with SPSS version 11.0 (SPSS, Inc., Chicago, Illinois, USA).
Results
From August 2000 until November 2004, a consecutive series of 100 
pregnancies complicated by severe second trimester TTTS were included in the 
study: 10 with Quintero stage 1 (10%), 42 with stage 2 (42%), 41 with stage 3 
(41%) and 7 with stage 4 (7%). The median gestational age at intervention was 
20 weeks (range 16-26). There were no cases of intra-amniotic bleeding that 
prevented completion of surgery. Rupture of membranes within 2 weeks of the 
procedure occurred in 13/100 (13%) cases. In 2 of these 13 cases there were 
clinical signs of chorioamnionitis. Of the 13 cases, 8 pregnancies ended within 
two weeks after the fetoscopic procedure and resulted in death of both fetus. 
The remaining 5 pregnancies resulted in at least one survivor at 4 weeks of 
age.
One woman suffered from a short episode of pulmonary oedema directly after 
laser procedure and was treated with oxygen and diuretics. Another woman 
presented a few months after delivery with complaints of bowel herniation in 
the mini-laparotomy scar. There were no other maternal complications.
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In five pregnancies (5%), polyhydramnios recurred, either in the sac of the 
former recipient (recurrence n=2) or in the sac of the former donor (reversal 
n=3). In two of these cases re-intervention with laser coagulation of the residual 
anastomoses was performed, both at 20 weeks. In the other three cases, 
caesarean section was performed at 29, 31 and 31 weeks, respectively. Table 1 
shows a comparison of the results of our series with those of other published 
series.7-10 Follow-up was complete until 4 weeks after birth. In our series, the 
incidence of single intrauterine fetal demise was 17% (17/100) (12 former 
recipients and 5 former donors). The incidence of miscarriage was 14% and the 
incidence of double intrauterine demise was 4%. The overall incidence of fetal 
Table 1 Comparison of perinatal outcome after fetoscopic laser surgery in the Leiden 

































































†  cohort studies 
*   randomised controlled trial
°  survival at 4 weeks
°°  survival at 6 months
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demise was thus 53% (53/200). Most fetal losses (81%, 43/53) occurred within 
4 weeks after the initial treatment. 
Neonatal death occurred in 8 children. Overall perinatal mortality was 61/200 
(30%). Perinatal survival of at least one child occurred in 81% (81/100) of 
TTTS pregnancies. There were no significant differences in perinatal survival 
according to placental localisation. Survival of at least one child was 30/38 
(79%, 95% CI 63-89) in anterior (complete or partial), and 51/62 (82%, 95% 
CI 71-90) in posterior placental localisation. Table 2 shows the pregnancy 
outcome by Quintero-stage. Perinatal outcome was significantly better in the 
early Quintero stages (p=0.02).
Discussion
We report the initial results of fetoscopic laser coagulation of vascular 
anastomoses for severe TTTS at our centre. In 81% of pregnancies, laser 
treatment resulted in the birth of at least one surviving child. These results 
are similar to those of other published large series.7-10 In contrast to Quintero 
et al who reported that stage is not an important prognostic factor when 
laser therapy is involved, we found that the earlier the stage at the time of 
treatment, the better the outcome.10 Double perinatal survival decreased 
Table 2 Pregnancy outcome after fetoscopic laser surgery for severe TTTS in the Leiden 










median gestational age at 
delivery
35 33 33 33
2 survivors at birth (%) 9/10 (90%) 29/42 (69%) 24/41 (59%) 3/7 (43%)
1 survivor at birth (%) 1/10 (10%) 6/42 (14%) 9/41 (22%) 1/7 (14%)
0 survivors at birth (%) 0/10 (0%) 7/42 (17%) 8/41(19%) 3/7 (43%)
(chi-square test, linear-by-linear association p=0.02)
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from 90% in Quintero stage 1 to 43% in Quintero stage 4. Our findings are 
in accordance with the results of a recent study reporting significantly better 
perinatal outcome of fetoscopic laser surgery in Quintero stage 1 and 2 as 
compared to stage 3 and 4.7
In untreated severe TTTS, perinatal survival rate is reported to range between 
20% and 37%.11-13 In treated severe TTTS, with serial amnioreduction or 
fetoscopic laser coagulation of vascular anastomoses, perinatal survival rates 
increase up to 57% and 66%, respectively.13 The incidence of neurological 
sequelae in TTTS is also related to the prenatal treatment modality. Severe 
neurological damage is found in 25% of survivors without prenatal treatment, 
in 16-22% in survivors after serial amniodrainage, and 5-11% after fetoscopic 
laser surgery.11;13-17 In a recent randomised multi-centre study, Senat et al 
found significantly better outcomes after fetoscopic laser surgery compared 
to serial amnioreduction. Survival of at least one twin at the age of six months 
was 51% in the amnioreduction group and 76% in the laser group (p=0.002). At 
the age of six months, major neurological sequelae were found in 19% of the 
surviving children after amnioreduction and in 7% after laser surgery (p=0.05). 
The overall higher mortality rate in this randomised trial in comparison with 
cited retrospective studies is probably due to a higher proportion of severe 
TTTS cases included, and to the fact that the authors followed the intention-
to-treat principle with inclusion of cases where intra-uterine death occurred 
between the moment of randomisation and treatment.7;12;13
In our centre, fetoscopic laser surgery was started in August 2000. To 
optimise the learning curve, each procedure was attended by two of the 
four operators. To evaluate the results of laser surgery we routinely perform 
placental injection study with coloured dye. The presence of four operators 
(presently FK, DO, FV, JM) guarantees the availability of at least one operator 
at all times, an obvious necessity for a national referral centre. In a recent 
editorial, Fisk et al debated the feasibility of fetoscopic laser surgery. They 
concluded that widespread adoption of this challenging and difficult procedure 
by fetal specialists without adequate training in endoscopy and placental 
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vascular anatomy has the potential to do more harm than good18. The results 
of fetoscopic laser treatment in our centre were from the beginning of the 
fetoscopy program comparable to those reported in the literature.19 We 
think, our results positively underline the statement of Fisk et al.18 Setting 
up a fetoscopic laser surgery program in a centre for fetal therapy is feasible, 
provided that adequate training is given, that operators receive feed-back by 
studying placental vascular anatomy after birth, that enough operators are 
available to run a 24 hours service, and that a minimum of 30 procedures 
per year are performed to ensure the maintenance of skills. The aim of each 
fetoscopic laser surgery program should also include accurate evaluation of 
short-term and long-term paediatric outcome. We have recently reported on 
the neonatal and short-term neurological outcome in TTTS treated with laser 
surgery at our centre.20;21 Long-term neurodevelopmental outcome at 2 years 
of age is currently being evaluated.
 
In our study, treatment in earlier Quintero stages resulted in significantly 
better outcome. Care should be taken when interpreting these results. A 
potential bias could be that not all early Quintero stages necessarily progress 
to higher stages. Luks et al studied natural evolution of 18 TTTS women in 
week-to-week evaluations and found no change in 72%, down-staging in 12% 
and up-staging in 15%.22 To prevent over-treatment in the 10-15% of cases that 
show spontaneous improvement, early TTTS stages can be followed closely, 
with laser treatment only in case of progression. On the other hand, waiting for 
TTTS to progress to higher stages may involve an increased risk of mortality 
and morbidity. It is still unknown, however, whether neurological damage 
in monochorionic twins treated with fetoscopic laser surgery occurs before, 
during or after laser surgery. As shown in a recent study, monochorionic 
twins without TTTS already are at considerable risk of developing neurological 
morbidity23. Thus, whether treatment in the early Quintero stages results in 
better outcome and prevents neurological morbidity can only be clarified in a 
randomised controlled trial between early laser and waiting for progression. 
Such a trial is urgently needed.
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Conclusion
Perinatal outcome in TTTS after fetoscopic laser coagulation of vascular 
anastomoses treated at our centre was similar to that in specialised foreign 
centres. Perinatal survival was significantly higher after laser surgery in the 
early Quintero stages.
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Abstract
Objective: To study the incidence and clinical implications of residual 
anastomoses in twin-to-twin transfusion syndrome treated with fetoscopic laser 
surgery 
Methods: We examined all placentas treated with fetoscopic laser surgery and 
delivered at our centre between June 2002 and December 2005 with vascular 
injection using coloured dyes. Presence of residual anastomoses was studied 
in association with adverse outcome and inter-twin haemoglobin difference at 
birth. Adverse outcome was defined as fetal demise, neonatal death or severe 
cerebral injury. The relation between residual anastomoses and placental 
localization (anterior or posterior uterine wall) was evaluated. 
Results: A total of 52 laser-treated placentas were studied. Residual 
anastomoses were detected in 33% (17/52) of placentas. Adverse outcome was 
similar in the groups with and without residual anastomoses, 18% (6/34) and 
29% (20/70) respectively (p = 0.23). Large inter-twin haemoglobin differences 
(> 5 g/dL) were found in 65% (11/17) of cases with residual anastomoses and 
20% (7/35) of cases without residual anastomoses (p < 0.01). Anterior placental 
localization was not associated with a more frequent presence of residual 
anastomoses. 
Conclusions: Residual anastomoses at our institution are seen in one third 
of monochorionic placentas treated with fetoscopic laser surgery. Although 
residual anastomoses in our study were not associated with adverse outcome, 
they were often associated with neonatal haematological complications.
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Introduction
Twin-to-twin transfusion syndrome (TTTS) presenting as oligo/polyhydramnios 
sequence is a major complication of monochorionic twin pregnancies and 
is due to inter-twin blood transfusion via placental vascular anastomoses. 
Fetoscopic laser coagulation of placental vascular anastomoses is nowadays 
considered to be the treatment of choice in severe second trimester TTTS. 
Fetoscopic laser surgery in TTTS is a causative treatment and is associated with 
significantly improved outcome compared to serial amniodrainage.1
The aim of laser coagulation of vascular anastomoses is to completely separate 
the inter-twin placental circulation. Careful examination of the placenta after 
birth through injection studies is required to determine whether all vascular 
connections have been adequately coagulated or whether residual anastomoses 
(RA) are still present.    
Although the first report of fetoscopic laser surgery was published more than 
15 years ago2, only few studies have since reported on the placental findings 
and incidence of RA after laser surgery.3-6 Most importantly, the results of 
these studies are highly discordant and the incidence or RA varied from 0% to 
75%.3-6 
The objective of our study was to determine the incidence and clinical 
implications of RA in a large series of placentas treated with fetoscopic laser 
surgery. We hypothesized that the presence of RA may lead to a higher 
incidence of adverse outcome and larger inter-twin haemoglobin difference 
at birth. Furthermore, we tested the hypothesis that RA may be found more 
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Material and methods
All consecutive placentas of monochorionic twin pregnancies with TTTS 
treated with fetoscopic laser surgery and delivered at our centre between June 
2002 and December 2005 were included in the study. The Leiden University 
Medical Centre is the national referral centre for laser treatment for TTTS in the 
Netherlands. TTTS was diagnosed using standard antenatal ultrasound criteria.7 
The fetoscopic laser surgery technique used was described in detail previously 
and is similar to the method reported by Hecher et al and Senat et al.1;8;9
After birth, presence of RA was studied by placental coloured dye injection. The 
umbilical vessels of both cords were injected with different-coloured dyes (blue 
or green for arteries and orange or yellow for veins). Injection was continued 
until dye was seen to flow through the distal end of the vascular tree and into 
the placental substance. Placentas were then photographed in a plane view, 
and the picture was saved in a computerized data base. Placentas were divided 
in two groups, a group with RA and a group without RA. Placentas of TTTS 
pregnancies with single or double intrauterine fetal demise were excluded 
when placental maceration prohibited accurate evaluation of RA. 
Adverse outcome was defined as intrauterine fetal demise, neonatal death 
or severe cerebral injury on neonatal ultrasound examination. The criteria 
used for determining severe cerebral injury were published in a previous 
study.10 Haemoglobin was measured at birth from cord blood. Anaemia and 
polycythemia at birth were defined as previously described.11
Results of categorical variables were compared using Chi-squared test. 
Continuous variables were analysed with the Independent Samples T- test. A 
p-value< 0.05 was considered to indicate a statistical significance. Statistical 
analysis was performed with SPSS version 11.0 (SPSS, Inc., Chicago, Illinois, 
USA).
62
Chapter 4 Residual anastomoses after fetoscopic laser surgery
Results
A total of 61 monochorionic placentas of TTTS pregnancies treated with 
laser were examined at our centre during the study period. Overall perinatal 
mortality was 21% (26/122: intrauterine fetal demise, n= 18; neonatal death, 
n = 8). The data required for this study could not be recorded completely for 
nine placentas due to maceration caused by single intrauterine fetal demise (n 
= 8) or placental fragmentation (n = 1). These nine cases were excluded from 
further analysis. Fifty-two placentas were thus included in the study. RA were 
found in 33% (17/52) of laser treated placentas. A total of 39 RA were detected, 
with an average of 2.3 (±1.7) RA per placenta. The type of RA detected were 
arterio-venous anastomoses from donor to recipient (n = 16), arterio-venous 
anastomoses from recipient to donor (n = 16), arterio-arterial anastomoses 
(n = 4) and veno-venous anastomoses (n = 3). Some placentas with RA (5/17) 
had multiple types of anastomoses. Twenty-five of the 39 (64%) RA were very 
small (< 1 mm diameter) (example shown in Figure 1 and 2). Superficial arterio-
arterial or veno-venous anastomoses were found in 35% (6/17) of placentas 
with RA. Adverse outcome occurred in 8% (1/12) of infants with superficial RA 
compared to 23% (5/22) in infants with only deep arterio-venous RA (p = 0.39). 
Further details on placentas, vascular anastomoses and clinical outcomes in 
the RA group and no-RA group are presented in Table 1. The ten cases of 
intrauterine fetal demise in the no-RA group were all double demises: 4 pairs of 
twins died within 2 weeks of laser surgery and one pair of twins died 6 weeks 
after laser surgery. 
In two of the 17 (12%) cases in the RA group, the presence of RA had 
already been predicted by the fetoscopic operator. In the first case a large 
arterio-arterial anastomosis was detected during fetoscopy but could not be 
coagulated due to its size. In the second case, surgery was complicated by 
intra-amniotic haemorrhage impeding further intervention due to blood-stained 
amniotic fluid. In two other cases (12%), presence of RA was suspected during 
the weeks following intervention because of fetal Doppler measurements (high 
middle cerebral artery peak systolic velocity (MCA-PSV) in one fetus). In the first 
case there was persistence of feto-fetal transfusion, in the second case there 
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Table 1 Characteristics of TTTS pregnancies with and without residual anastomoses
RAe group
(n = 17 twin 
pairs)
no-RAe group
(n = 35 twin 
pairs)
p-value
Gestational age at laser surgery 
– weeksa 19.9 ± 4.1 20.6 ± 3.2 0.51
Anterior placentab 5 (29%) 11 (31%) 0.83
Number of anastomoses coagulated 
per placentaa 7.2 ± 4.5 6.0 ± 2.6 0.23
Gestational age at birth – weeksa 31.8 ± 3.2 31.1 ± 5.2 0.61
Birth weight – ga,c 1718 ± 608 1633 ± 855 0.60
Inter-twin birth weight difference > 
20%b 7 (41%) 11 (31%) 0.49
Intrauterine fetal demiseb,c 0 (0%) 10 (14%) 0.02
Neonatal deathb,c 1 (3%) 6 (9%) 0.28
Severe cerebral injuryb,c 6 (18%) 7 (10%) 0.27
Adverse outcomeb,c,d 6 (18%) 20 (29%) 0.23
a Value given as mean ± SD
b Percentages are between brackets
c Refers to single infants instead of twin pair
d Adverse outcome was defined as intrauterine fetal demise, neonatal death or severe 
cerebral injury
e RA: residual anastomoses 
Table 2 Haemoglobin values at birth in TTTS pregnancies with and without residual 
anastomoses
RAc group
(n = 17 twin pairs)
no-RAc group
(n = 35 twin pairs)
p-value
Haemoglobin – g/dLa 15.4 ± 5.6 16.0 ± 3.8 0.60
Anaemia in one twinb 9 (26%) 8 (11%) 0.06
Polycythaemia in one twinb 4 (12%) 2 (3%) 0.07
Inter-twin haemoglobin difference > 
5 g/dLb 11 (65%) 7 (20%) < 0.01
Twin pairs with anaemia or 
polycythaemiab 10 (59%) 8 (23%) 0.01
a Value given as mean ± SD
b Percentages are between brackets
c RA: residual anastomoses 
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was a reversal of feto-fetal transfusion. In the remaining 13 cases (76%), RA had 
not been suspected antenatally. 
The results of haematological values at birth are presented in Table 2.
Figure 1Placenta of TTTS-pregnancy treated with laser at 17 week’s gestation, followed by 
spontaneous delivery of 2 healthy girls at 38 weeks. The placental share of the ex-donor 
(birth weight 3055 gr) is on the left-side of the picture (arteries are blue, veins are orange). 
The placental share of the ex-recipient (birth weight 2915 gr) is on the right-side (arteries 
are green, veins are yellow). Haemoglobin level in the ex-donor and ex-recipient were 13.2 
g/dL and 19.2 g/dL respectively. The white arrows indicate the successfully coagulated 
anastomoses. The light blue arrow indicates a residual veno-venous anastomosis. A very 
small residual arterio-venous anastomosis from the ex-donor to the ex-recipient is in the white 
square that is enlarged in Figure 2.
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Figure 2 Detail of the very small residual anastomosis (diameter < 1 mm) between an artery 
(blue) from the ex-donor and a vein (yellow) from the ex-recipient.
Discussion
This study is the first large single centre study reporting on the frequency and 
clinical implications of RA after fetoscopic laser surgery. We found that RA are 
present in one third of laser treated placentas. In a small study, De Paepe et al 
found a much higher incidence of RA in laser treated placentas, namely 75%.3 
Quintero et al, on the other hand, described a much lower incidence of RA, 
ranging from 0% to 5%.4-6 Such an extreme discrepancy between the various 
studies can be due to several factors, namely (1) number of placentas studied, 
(2) differences in laser technique and surgical results and (3) differences in 
placental injection techniques. Obviously, no reliable conclusions on incidence 
of RA can be drawn if the number of studied placentas is too small. De Paepe 
et al, for example, were able to study only 8 placentas.3 The second factor, 
adequate identification and successful coagulation of vascular anastomosis, 
probably depends on the ability of each fetal surgeon. Hecher et al reported an 
association between improved outcome and growing experience in the laser 
technique, possibly attributable to an improved efficiency in laser surgery.9 
However, the relation between RA and inter-individual or inter-centre variation 
in fetoscopic laser surgery has not been studied. Nevertheless, we have 
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previously shown that the overall outcome after laser surgery in our centre is 
similar to that in other large centers.8 Finally, the third factor, differences in 
placental injection technique, may influence the results on the incidence of 
RA. Discordant opinions on the sensitivity of various injection methods have 
recently resulted in a fierce debate in the literature.12 Quintero et al performed 
placental injection studies with air and claimed that this method has similar 
sensitivity compared to other methods.6;13 Most other authors, as well as our 
group, advocate placental injection with coloured dye.3;14-19 Which of the two 
methods (air injection or coloured dye injection) is superior in detecting RA is 
not known. However, in our experience, the vast majority of RA are very small 
(with diameters < 1mm) and therefore difficult to detect without accurate 
injection with coloured dye.
Several reasons can be envisaged to explain the occurrence of RA, namely 
(1) anastomoses (particularly the minuscule ones) were not detected during 
fetoscopy, (2) anastomoses were not coagulated because surgery was too 
selective in order to spare cotyledons, (3) placental vessels of the donor were 
collapsed due to hypovolemia and vasoconstriction preventing adequate 
detection, (4) insufficient coagulation led to temporary anastomotic flow 
obstruction, but revascularization occurred later, and (5) anastomoses were 
detected during fetoscopy, but were considered too large to tackle. These 
reasonings may have consequences for the laser surgery technique. If (1), (2) 
or (3) are true, RA can be avoided using a technique of complete coagulation 
(with a 5 mm width) of the entire vascular equator. If (4) is true, then RA can be 
avoided by creating sufficient placental damage using a technique of deeper, 
longer-lasting and more frequent coagulation.
This study shows that, despite the fact that laser surgery in anterior 
placentas is technically more complex, anterior placentas are not associated 
with increased incidence of RA. Furthermore, the overall outcome of TTTS 
pregnancies with RA in our study was similar to those in TTTS pregnancies 
without RA. Both hypotheses, that RA could be associated with anterior 
placentas and adverse outcome, were thus not confirmed in our study. Lack 
of association between RA and adverse outcome may partly be due to the 
frequent presence (35%) of residual superficial anastomoses. Superficial arterio-
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arterial anastomoses are known to protect against TTTS.20
An important (but inevitable) bias in our study may have been introduced by 
the exclusion of nine cases in which placental fragmentation or post-mortem 
placental changes prohibited the injection and demonstration of the vessels 
on the placental surface. Adverse outcome in the nine excluded pregnancies 
was 50% (9/18; intrauterine fetal demise: n = 8, severe cerebral injury: n =1). If 
adverse outcome in these pregnancies would have been caused by RA, then the 
incidence of adverse outcome in the RA group would have increased from 18% 
(6/34) to 29% (15/52). This is still similar to the incidence of adverse outcome 
in the no-RA group (29%) (p = 0.97). Therefore, it seems reasonable to deduce 
that RA in our study were not associated with adverse outcome. 
We have shown in this study that large inter-twin haemoglobin differences (> 5 
g/dL) were significantly more frequent in the presence of RA compared to the 
group without RA. Therefore, the hypothesis related to the association between 
RA and larger inter-twin haemoglobin difference seems legitimate. RA were also 
associated with a higher incidence of anaemia or polycythemia at birth. Overall, 
RA were associated with isolated haemoglobin discordance at birth or recurrent 
TTTS in 11 of the 52 (21%) TTTS pregnancies treated with laser surgery. Our 
findings are in agreement with recent reports suggesting that incomplete 
coagulation results in isolated haemoglobin discordance or recurrent TTTS in 
up to 27% of double survivors after laser surgery.21-23 Routine serial ultrasound 
examination with MCA-PSV measurement after laser surgery proved invaluable 
in the early detection of severe fetal haematological disorders and is nowadays 
strongly recommended.21-23 Similarly, we also strongly recommend routine 
placental injection study in TTTS treated with laser because it may give equally 
invaluable information to perinatologists to understand the etiology of severe 
haematological disorders. Finally, placental injection studies are an important 
feedback source to individual fetoscopic surgeons.
In conclusion, clinicians involved in the care for monochorionic twins should be 
aware that RA occur frequently after fetoscopic laser surgery in TTTS. Although 
RA are not clearly associated with adverse outcome, these anastomoses may 
be associated with severe haematological disorders in fetuses and neonates. 
Routine Doppler measurements after laser surgery and accurate placental 
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injection studies after birth can help in detecting and understanding fetal and 
neonatal haematological complications. 
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Abstract
Objective: Laser coagulation of anastomotic vessels on the placental 
surface is the treatment of choice in severe second trimester twin-
to-twin transfusion syndrome (TTTS). This procedure is associated 
with technical difficulties when the placenta is located on the anterior 
side of the uterus. We describe a novel technique for fetoscopy in 
TTTS with completely anterior placenta where laparoscopy is used to 
guide safe percutaneous insertion of the fetoscope through the lateral 
abdominal wall and the dorsal side of the uterus.
Methods: Prospective controlled series of 16 TTTS pregnancies with completely 
anterior placenta (study group) treated with this novel technique.  Studied 
outcomes were technical result of the procedure and perinatal survival. 
Outcome in the study group was compared with outcome of 49 TTTS 
pregnancies treated with conventional percutaneous fetoscopic laser without 
laparoscopy, 9 of these with partially anterior placenta (control group A) and 40 
with lateral or posterior placenta (control group B). 
Results: In the study group, the procedure-related complication rate was 25% 
(4/16). In one case uterine entry of the fetoscope from the lateral abdominal 
wall was not possible due to complex bowel adhesions. In 3 patients, 
intraamniotic haemorrhage occurred after fetoscopic entry, preventing 
complete laser coagulation of anastomoses. One of these patients required 
two units of blood transfusion. The procedure-related complication rate in 
control group A and B was 22% (2/9) and 5% (2/40), respectively (intraamniotic 
haemorrhage n =3, severe leakage of amniotic fluid into the peritoneal cavity, 
n=1). Perinatal survival in the study group, control group A and control group B 
was 63% (20/32), 78% (14/18) and 70% (56/80), respectively.
Conclusions: Combined laparoscopy and fetoscopy is a novel technique 
that enables safe uterine entry and creates optimal visualisation for laser 
coagulation of intertwin anastomoses in TTTS pregnancies with completely 
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anterior placenta. Procedure-related complication rate and perinatal survival 
rate were similar compared to the conventional percutaneous technique. 
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Introduction
Monochorionic twin pregnancies are at risk for developing twin-to-twin 
transfusion syndrome (TTTS) due to unbalanced intertwin blood-flow through 
placental vascular anastomoses. TTTS occurs in approximately 15% of 
monochorionic twin pregnancies during the second trimester.1 The prognosis 
for untreated severe second trimester TTTS is poor.2 Since 1980, serial 
amniodrainage has been used as a symptomatic therapy. A decade later, a 
cause-oriented approach for TTTS was developed: fetoscopic laser coagulation 
of placental vascular anastomoses.3-5 In a recent randomised trial of severe 
second trimester TTTS, perinatal survival rates and neurological outcome at 
six months of age were significantly better after laser treatment compared to 
amniodrainage.6
In patients with placental localisation on the posterior wall of the uterus, 
percutaneous insertion of the fetoscope for laser coagulation gives 
perpendicular access to the chorionic plate and the vascular anastomoses on 
its surface, and is, in experienced hands, a straightforward procedure. An angle 
of approximately 90 degrees between chorionic plate and fetoscope and laser 
fibre provides maximal visualisation of the vascular equator and optimal laser 
effectiveness. An anterior placenta, however, presents a technical challenge, 
because perpendicular access is not possible. Several authors have claimed that 
the problem of anterior placentas could be solved either by open uterine access 
via mini-laparotomy, or by lateral percutaneous entry combined with the use 
of a curved shaft and flexible fetoscope, with the use of multiple ports, or with 
lateral view fetoscope and side firing laser.7-11 These methods, however, still 
entail a higher risk of transplacental entry, maternal bowel or uterine vessel 
damage, increased risk of iatrogenic rupture of membranes, or incomplete 
placental visualisation and diminished laser effectiveness and thus of 
incomplete laser treatment. We report on a novel minimally invasive technique, 
developed to enable safe uterine entry and optimal placental visualisation in 
patients with completely anterior placenta by combining laparoscopy with 
fetoscopy. Laparoscopy with open entry technique has been shown before to 
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be a safe procedure in pregnant women.12;13 
In this study, we describe this new technique and report on the procedure-
related complications and on perinatal survival in the first 16 patients with 
completely anterior placenta treated with combined laparoscopy and fetoscopy. 
We compared procedure-related complications and perinatal survival in this 
study group with those of two control groups that underwent fetoscopy without 
laparoscopy for TTTS: control group A with partially anterior placenta and 
control group B with lateral or posterior placenta.
Patients
Our centre is the national referral centre for invasive fetal therapy in the 
Netherlands. In August 2000, we started our program of fetoscopic laser 
coagulation of anastomotic vessels for severe TTTS.14 In September 2003, we 
performed our first combined open laparoscopy and fetoscopy for completely 
anterior placenta. Completely anterior placenta was defined as a placenta and 
stuck twin covering almost the entire ventral uterine wall, thereby excluding 
the avoidance of transplacental entry, or enhancing the risk of damaging 
maternal bowel or vessels, or excluding complete visualisation of the vascular 
equator with percutaneous fetoscopic entry. To evaluate this new technique, we 
compared the procedure-related complications and the perinatal survival with 
those of 49 routine laser procedures performed by our team during the same 
time period. Perinatal survival was assessed until 4 weeks after birth. Inclusion 
criteria for laser surgery were: monochorionic twin pregnancy, gestational age 
between 15 and 27 completed weeks, TTTS Quintero stage 1 with severe clinical 
symptoms of polyhydramnios, or TTTS Quintero stage ≥ 2. Patients in active 
labour or with a fetus with congenital malformations were excluded. Before 
fetoscopy, detailed sonographic evaluation was performed to exclude congenital 
anomalies, to confirm the diagnosis of TTTS, and to determine the Quintero 
stage. The sonographic investigation included: fetal anatomy and biometry, 
deepest vertical pocket of amniotic fluid of each fetus, bladder filling, arterial 
and venous Doppler studies, placental localisation, and localisation of umbilical 
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cord insertions. Based on the placental localisation, the position of both fetus 
and the insertion site of the umbilical cords, an estimation was made of the 
localisation of the vascular equator on the placenta. 
Operative technique
Under general anaesthesia and with the patient in supine position, open 
laparoscopy was performed according to the technique first described by 
Hasson.15 We modified the technique by introducing the Origin balloon trocar 
(Autosuture®, Tyco Healthcare, Gosport, UK) with blunt tip, after the abdomen 
had been opened, via a 2 to 3 cm median or paramedian incision. This incision 
was made 2 cm above the fundus of the uterus (figure 1a). Pneumoperitoneum 
was established under direct vision of the laparoscope. The intra-abdominal 
CO2 insufflation pressure was automatically regulated and maintained at 12-14 
mm Hg. After insertion of the laparoscope, the patient was turned to lateral tilt 
position and stabilised using a desufflatable beanbag. The fetoscopic insertion 
site was chosen near the mid-axillary line, between the lower ribs and the iliac 
crest (figure 1b). At this site, an 18-G needle was inserted into the abdominal 
cavity under laparoscopic vision, away from bowel. In some cases, in order to 
obtain better visualisation, a second trocar was inserted close to the needle 
insertion site and the laparoscope was then switched to the second trocar. 
Figure 1a and 1b Skin incisions made for open laparoscopy (a), and fetoscopic entry (b).
A B
78
Chapter 5 Laparoscopically guided fetoscopy in TTTS with completely anterior placenta
Under direct laparoscopic view, the 18-G needle was inserted safely into the 
posterior uterine wall, away from the large vessels on the lateral side of the 
uterus (figure 2). Simultaneously, ultrasound was used to guide the needle 
into the amniotic cavity of the recipient fetus. Then a Seldinger technique was 
used with a 0.085 inch soft J-tipped guide wire that was introduced through 
the needle, which was then removed.7 A 10 F teflon cannula, loaded with a 
dilator, was advanced over the guide wire (Cook®). When the cannula had 
entered the amniotic cavity, the guide wire and dilator were removed and 
the shaft loaded with a 2 mm fetoscope (Storz, Vianen, the Netherlands) and 
laser fibre (400 μm) (Dornier Medizin Technik, Germering, Germany) was 
inserted. This procedure was also sonographically guided. For this purpose, the 
pneumoperitoneum had to be partly released. Figure 3 shows an ultrasound 
picture with the ultrasound probe at the maternal umbilicus and pushed 
against the uterus, and the fetoscope entered through the dorsal uterine 
wall. The fetoscopic laser coagulation then took place following the standard 
procedure, with the advantage of perpendicular access to and complete 
visualisation of the placenta.14
In the control group an 18-G needle that was inserted percutaneously in the 
uterine cavity under ultrasound guidance. The same procedure as described 
Figure 2 
Laparoscopic view 
of the needle in 
the intraperitoneal 
cavity just after 
entering the dorsal 
uterine wall. Open 
laparoscopy was 
performed in 
the right upper 
quadrant, 3 cm 
under lower ribs.1 
right dorsolateral 
abdominal wall, 
2 needle insertion 
at posterior side 
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above was then used for insertion of the fetoscopic shaft. Curved shafts up 
to 40 degrees and a semi rigid fetoscope were used when indicated. Patients 
underwent this conventional percutaneous entry procedure under local or 
loco-regional anaesthesia. In both groups, a prophylactic dose of tocolytics 
(indomethacin) and antibiotics (amoxycillin/clavulanate) was given routinely.
Statistics
Differences in gestational age between study and control groups were analysed 
with one-way analysis of variance. Categorical variables were analysed with 
Fisher exact test, chi square test, and linear by linear association for trend. A 
p-value < 0.05 was considered to indicate a statistical significance. Statistical 
analysis was performed with SPSS version 11.0 (SPSS, Inc., Chicago, Illinois, 
USA).
Results
Between September 2003 and December 2005, treatment with fetoscopic laser 
coagulation of anastomotic vessels was performed in 65 patients. Anterior 
placenta was detected in 38% (25/65) of patients. In 64% of these (16/25), 
Figure 3 Transverse sonographic view (transducer at maternal umbilicus) of the uterus with 
fetoscopic entry site in the dorsal uterine wall.
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the placenta completely covered the anterior uterine wall. These 16 patients 
underwent the combined open laparoscopy and fetoscopy procedure. Of the 49 
patients without completely anterior placenta, 9 (18%) patients had an anterior 
placenta that only partially covered the anterior uterine wall (control group A), 
and 40 (82%) patients had lateral or posterior placenta (control group B). 
Details of the 16 patients in the study group are listed in Table 1. In 2 of 
the 16 patients, the combined open laparoscopy and fetoscopy was the 
second procedure for the treatment of TTTS. One patient underwent a prior 
amniodrainage and in another patient a routine laser procedure had been 
attempted 9 days earlier, which had to be abandoned after the occurrence of 
significant intraamniotic haemorrhage at uterine entry. In 4 of the 16 patients, 
laser coagulation could not be performed. In one patient, uterine entry was 
not possible despite assistance of the laparoscope, because of complex bowel 
adhesions along the lateral side of the uterus. Instead, an amniodrainage 
procedure was performed. In three other patients, severe intraamniotic 
haemorrhage occurred. Because of impaired visualisation shortly after entry, 
the procedure was abandoned. One of these patients also suffered from an 
intraperitoneal bleeding from the uterine wall and received two units of blood 
transfusion. 
In 4 of the 49 patients in the control groups, laser coagulation was not or 
incompletely achieved. In 3 of these 4 patients (2 in control group A and 1 in 
control group B) intraamniotic haemorrhage occurred. In the fourth patient (in 
control group B), no visualisation could be reached, due to rapid leakage of all 
of the amniotic fluid into the intraperitoneal cavity after a sudden movement of 
the patient. In two other cases in control group B, recurrence o f the syndrome 
and reversal of the syndrome were diagnosed, respectively. There was no 
significant difference in procedure-related complication rate between the 
laparoscopy (study) group and the conventional fetoscopy group (combination 
of control group A and B) (p = 0.094). When comparing the women with 
anterior placenta (combination of study group and control group A) with 
the women with posterior placenta (control group B), a significantly higher 
procedure-related complication rate was found in the anterior placenta group 
(p = 0.047). There was a significant linear-by-linear trend for higher procedure-
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Table 1 Characteristics of 16 cases of laparoscopically assisted fetoscopic intervention for twin-
to-twin transfusion syndrome with completely anterior placenta 










complications leading to 
incomplete treatment
1 II 15 31 2
2 IV 21 33 2
3 II 17 37 2
4 III 20 33 2
5† I 24 37 2
6 I 17 23 0
no intra-uterine access 
due to bowel adhesions, 
amniodrainage
7 III 19 29 0
8 III 24 35 2
9 II 18 19 0
10‡ III 26 28 1
11 III 20 29 1
intraamniotic haemorrhage, 
laser coagulation not 
achieved, amniodrainage + 
cord coagulation
12 III 20 29 2
13 I 19 20 0
intraamniotic haemorrhage, 
laser coagulation not 
achieved, amniodrainage
14 III 15 28 2
intraamniotic haemorrhage, 




15 III 20 22 0
16 III 16 31 2
†   previous amniodrainage at 20 weeks
‡ previous attempt to percutaneous laser coagulation at 25 weeks 
82
Chapter 5 Laparoscopically guided fetoscopy in TTTS with completely anterior placenta
related complication rate towards less favourable placenta localisation (p = 
0.029).
No significant differences in 0, 1 and 2 survivors and perinatal survival were 
found between the three groups (p = 0.348). Further details on procedure-
related complication rate and perinatal survival in study group and control 
groups are reported in table 2.
Table 2 Perinatal outcome after laser coagulation of vascular anastomoses in the study 
group (laparoscopically assisted fetoscopic entry with completely anterior placenta), control 
group A (percutaneous fetoscopic entry with partial anterior placenta) and control group B 








Lateral or posterior 
placenta
N=40
gestational age at 
intervention† - 
20 (15-26) 18 (15-26) 20 (15-26)
procedure-related 
complication - no.(%)
4 (25%) 2 (22%) 2 (5%)
gestational age at 
birth† - 
29 (19-37) 31 (15-36) 31 (16-38)
0 survivors‡ - no.(%) 5 (31%) 2 (22%) 7 (17%)
1 survivor‡ - no.(%) 2 (13%) 0 (0%) 10 (25%)
2 survivors‡ - no.(%) 9 (56%) 7 (78%) 23 (58%)
at least 1 survivor‡ 
- no.(%)
11 (69%) 7 (78%) 33 (83%)
neonatal death - no.(%) 1/32(3%) 0/18 (0%) 1/80 (1%)
perinatal survival‡ - 
no.(%)
20/32 (63%) 14/18 (78%) 56/80 (70%)
† median (range) in completed weeks
‡ 4 weeks after birth
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Discussion
We describe a novel minimally invasive technique for safe fetoscopic entry 
through the posterior uterine wall in patients where the placenta completely 
covers the anterior uterine wall. This safe entry was accomplished by 
laparoscopic guidance of the fetoscope, thus avoiding the risk of bowel 
damage at peritoneal entry and of vascular damage at uterine entry. 
Our findings suggest that perinatal survival rate and procedure-related 
complications rate associated with this novel technique are similar compared to 
the conventional percutaneous laser technique without laparoscopy. However, 
procedure-related complication rate remained higher in the group with partly 
and completely anterior placenta compared to the group with posterior 
placenta. 
Since the development of the technique of fetoscopic laser coagulation, 
patients with an anterior placenta have presented a technical challenge. In the 
first series of De Lia et al, patients with anterior placenta were excluded
from fetoscopic laser surgery.4 In the second series of De Lia et al, 46% of 
patients had an anterior placenta and underwent midline laparotomy with the 
uterus exteriorised for optimal insertion of the fetoscope.16 Nowadays, De 
Lia is still using this operation technique in patients with a completely anterior 
placenta (personal communication). In the first series of Ville et al, 40% of the 
patients had an anterior placenta.5 In this study, a rigid fetoscope was used and 
the same procedure was used for anterior placenta as for posterior placenta 
localisation. The author stated that adequate visualisation of the intertwin 
membrane and coagulation of the crossing vessels was more difficult to 
achieve in the patients with anterior placenta. In the second series of Ville et al, 
which included patients of their first series, 43% of the patients had an anterior 
placenta.10 In this series of 57 patients, the percutaneous insertion site of the 
fetoscope was chosen as lateral as possible and sonographically guided by 
colour Doppler to avoid the uterine vessels. Nevertheless, in 9 of their patients 
the entry was transplacental. They state, however, that good visualisation of 
intertwin membrane and crossing vessels was achieved in all cases. Deprest 
et al also recognised the technical problems of an anterior placenta. They 
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described an alternative technique for fetoscopic access in patients with 
anterior placenta, using mini-laparotomy mainly in the region of the uterine 
fundus, Seldinger technique for uterine entry and a curved shaft with a semi-
rigid fiberscope.7 In the series of Zikulnig et al, 36% of the patients had an 
anterior placenta.8 They mentioned that, when using the lateral percutaneous 
technique, the procedure succeeded in most cases, though more technical 
difficulties were encountered in achieving good visualisation and coagulation 
of vessels. Hecher et al, stated that, in most patients with anterior placenta, 
the lateral percutaneous fetoscopic access provided good visualisation of most 
vascular anastomoses, although detailed results were not reported.9 Quintero 
et al described two techniques for the laser treatment in women with anterior 
placenta. The first technique entails the use of a flexible scope through a 
single port. The second technique is based on the use of a side-firing laser 
fibre through one port and a rigid angled-view endoscope through a second 
port. No significant differences in survival were found, but operating time 
was significantly increased for those with an anterior placenta.11 Yamamoto 
et al reported on incidence and impact of perioperative complications in 
175 fetoscopy-guided laser coagulation procedures.17 Transplacental entry 
occurred in 27% of the cases and was 5 times more frequent when the placenta 
was anterior. Intraamniotic haemorrhage was 3 times more frequent with 
transplacental entry. However, position of the placenta and transplacental entry 
were not correlated with the outcome. 
Although the majority of authors do not find significant differences in 
perinatal survival between cases with anterior and with posterior placenta, 
many authors mention the fact that anterior placenta presents a technical 
challenge because of impaired visualisation of the placental surface. All but 
one published series of fetoscopic laser coagulation of vascular anastomoses 
were non-randomised prospective studies. Possibly, some of the patients with 
a completely anterior placenta would not have been included in these series, 
because of the anticipation on technical problems of percutaneous fetoscopic 
laser coagulation.
Our technique is an alternative to the existing techniques aimed on being 
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minimally invasive and providing a close to 90 degrees perpendicular 
intra-uterine access for optimal visualisation and laser effectiveness, with 
simultaneous avoidance of the maternal intraperitoneal structures. We agree 
with other authors that in a substantial number of patients with an anterior 
placenta, lateral percutaneous fetoscopic access provides acceptable conditions 
for laser surgery. During the study period, 9 of 25 patients with an anterior 
placenta underwent fetoscopic laser coagulation using the conventional 
percutaneous fetoscopic entry. However, in patients with completely anterior 
placenta, this procedure still entails a risk of transplacental entry or incomplete 
laser surgery.17 Procedure-related complication rates in completely anterior 
placenta have not yet been reported. We found that 2 of 4 procedure-related 
complications in the control groups occurred in the control group with partially 
anterior placenta, confirming the suggestion that fetoscopic procedures 
carry more risks in patients with an anterior placenta. Procedure-related 
complications also occurred in the study group in which we performed the 
laparoscopic procedure. However, this group of patients was a highly selective 
group where the placenta covered the complete anterior uterine wall and no 
placenta-free site could be identified for safe lateral percutaneous fetoscopic 
entry. This may explain the higher number of procedure-related complications 
towards less favourable placental localisation.
Laparoscopically guided fetoscopy also has some limitations. Firstly, 
abdominal adhesions may hamper application of this technique. Secondly, 
we found an 18% risk of intraamniotic bleeding in our study group. This may 
be by coincidence, as the incidence of intraamniotic bleeding did not differ 
significantly between the study group and the two control groups, and as 
the overall incidence, 6/65 (9.2%), of intraamniotic bleeding in both study 
and control groups was very similar to the 8.6% found by Yamamoto et al.17 
However, the high risk of intraamniotic bleeding in the study group may also 
be explained by the limited value of colour Doppler for identification and 
avoidance of vasculature when the uterine entry site is posterior. Also, the use 
of general anaesthesia for laparoscopy may promote uterine relaxation and 
thus the risk of bleeding at perforation. 
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Conclusions
Laparoscopically assisted fetoscopic uterine access through the dorsal uterine 
wall for laser coagulation of vascular anastomoses in patients with severe TTTS 
is a novel technique. This technique enables safe uterine entry in a selected 
group of patients with an anterior placenta covering the complete anterior 
uterine wall. There were no significant differences in perinatal survival between 
the laparoscopically guided and the conventional percutaneous fetoscopic 
entry technique. However, procedure-related complication rate remained higher 
in women with anterior than in women with posterior placental localisation. 
Further comparison between laparoscopically guided fetoscopy and alternative 
approaches may form the subject of prospective controlled trials.
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Abstract
Objective: To determine the long-term neurodevelopmental outcome in twin-to-
twin transfusion syndrome (TTTS) treated with fetoscopic laser surgery. 
Methods: All TTTS-cases treated at our centre with laser between August 
2000 and December 2003 were included in the study. Neurological, mental 
and psychomotor development at 2 years of age corrected for prematurity 
was assessed in all TTTS-survivors. Neurodevelopmental impairment was 
defined as any of the following: cerebral palsy, deafness, blindness, mental or 
psychomotor development index of the Bayley Scales of Infant Development II < 
2 SD.
Results: A total of 82 TTTS pregnancies were treated with fetoscopic laser 
surgery during the study period. Perinatal survival was 70% (115/164). The 
incidence of neurodevelopmental impairment was 17% (19/115) and was due 
to cerebral palsy (n = 8), mental developmental delay (n = 9), psychomotor 
developmental delay (n = 12) and deafness (n = 1). 
Conclusions: The incidence of neurodevelopmental impairment in TTTS-
survivors treated with laser is high and warrants long-term follow-up. 
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Introduction
Monochorionic twinning predisposes to cerebral damage due to complications 
caused by twin-to-twin transfusion (TTTS). TTTS occurs in approximately 
15% of monochorionic pregnancies and results from shunting of blood 
from one twin, the donor, to the other twin, the recipient, through placental 
vascular anastomoses. Untreated, TTTS is associated with high perinatal 
mortality and morbidity.1 The two current treatment options in TTTS are serial 
amnioreduction and fetoscopic laser occlusion of vascular anastomoses.1-
4 In a recent randomized trial comparing serial amnioreduction and laser 
treatment, perinatal survival and neurological outcome at six months of age 
was significantly better in the group treated with laser.5 Although fetoscopic 
laser occlusion of vascular anastomoses is increasingly being advocated as 
the preferred treatment for TTTS, only a few studies have been published on 
the long-term neurodevelopmental outcome following such treatment. The 
incidence of major neurological abnormalities in these reports varied from 6% 
to 11%.6-8
The main objective of our study was to evaluate long-term neurodevelopmental 
outcome in a large group of TTTS-survivors after treatment with fetoscopic 
laser surgery.  
Patients and methods
All survivors of consecutive TTTS-cases treated with fetoscopic laser surgery 
between August 1, 2000 and December 31, 2003 at the Leiden University 
Medical Centre were included in the study. The Leiden University Medical 
Centre serves as the national referral centre for intrauterine laser treatment 
in TTTS pregnancies in the Netherlands. TTTS was diagnosed using 
standard prenatal ultrasound criteria, and staged according to the criteria of 
Quintero.9;10 The following perinatal data were recorded: gestational age at 
the time of laser treatment, stage of TTTS, gestational age at delivery, mode of 
delivery and birth weight. 
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The follow-up visit was assessed at 2 years of age (corrected for prematurity) 
and included a physical and neurological examination and an assessment 
of cognitive and neuromotor development using the Dutch version of the 
Bayley Scales of Infant Development, 2nd edition (BSID-II) (both by certified 
examiners). Bayley scale scores provide mental developmental indexes (MDI) 
and psychomotor development indexes (PDI). Each of these indexes has a 
mean score of 100. When each separate index score was below 70 (i.e. > 2 SD 
below the mean score), this was indicative of a severe delay in either mental 
development or psychomotor development. Infants with very low MDI or PDI 
scores (< 50) were assigned a score of 49 in the database. Cerebral palsy (CP) 
was defined according to the European CP Network and classified as diplegia, 
hemiplegia, quadriplegia, dyskinetic or mixed.11 
A composite outcome, termed neurodevelopmental impairment, was defined as 
any of the following: CP, MDI score of less than 70, PDI score of less than 70, 
bilateral blindness, or bilateral deafness requiring amplification. Outcome was 
compared between donor and recipient twins. 
The institutional review board of the Leiden University Medical Centre approved 
the study and all parents gave written informed consent for their children.
Statistics
Results of categorical variables were compared using Fisher’s exact test 
or Chi-square test, as appropriate. Unpaired Student’s t test was used to 
compare normally distributed values between two groups. For comparisons 
between donors and recipients, the paired Student t test was used for normally 
distributed continuous variables and the Mc Nemar test for analysis of paired 
nominal variables. Multiple logistic regression analysis with “random twin 
effect” was used to measure the independent effects of potential prognostic 
factors on outcome. A model with “random twin effect” was applied to adjust 
for possible correlated effects within twins. The results of the logistic models 
were expressed as an odds ratio (OR) and 95% confidence intervals (CI). Chi-
square test for trend was used in order to evaluate the relationship between 
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stage of TTTS and outcome. A p-value <0.05 was considered to indicate 
statistical significance. Analysis was performed using SPSS version 11 (SPSS 
Inc., Chicago, IL, USA). Multiple logistic regression analysis was performed 
with EGRET version 2.0.1 for Windows (Cytel Software Corporation, Cambridge, 
Massachusetts, USA).
Results 
During the study period, 82 TTTS pregnancies were treated with fetoscopic 
laser surgery at our centre. Quintero stage was I in 9 cases, II in 35 cases, III 
in 32 cases and IV in 6 cases. Laser surgery treatment for Quintero stage I was 
only performed when symptomatic polyhydramnios warranted intervention. 
Mean gestational age at laser surgery was 20.0 weeks (range 15 to 28 weeks; 
2 TTTS pregnancies were treated after 26 weeks’ gestation). Intrauterine 
fetal demise occurred in 41 fetuses (single intrauterine fetal demise, n = 15; 
double intrauterine fetal demise, n = 26). Mean gestational age at birth of the 
surviving infants was 33.9 ± 3.1 weeks (range: 27 to 40 weeks). Neonatal death 
occurred in 8 neonates. Overall perinatal survival was 70% (115/164). We were 
able to follow-up all 115 surviving twins. Four families refused to travel to our 
centre for follow-up visit due to the long travel distance, but agreed to allow 
the complete follow-up examination (including BSID-II test) at their own home. 
Baseline characteristics of the TTTS survivors are presented in Table 1. 
The incidence of neurodevelopmental impairment was 17% (19/115) and was 
due to cerebral palsy (n = 8), severe mental developmental delay (n = 9), severe 
psychomotor developmental delay (n = 12) and deafness (n = 1). Cerebral 
palsy was classified as quadriplegia (n=4), diplegia (n= 2) and hemiplegia (n= 
2). Details on the combinations of abnormal findings detected in the infants 
with adverse outcome are presented in Table 2.  Characteristics and outcome 
in surviving donor and recipient twins at 2 years of age are presented in 
Table 3. Donor twins were smaller at birth than recipient twins, and remained 
significantly smaller at 2 years of age (p < 0.001). We found no difference in 
neurodevelopmental outcome between donor and recipient twins.
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Table 1 Baseline characteristics in the 115 TTTS long-term survivors
Long-term survivors 
 (n = 115 infants)
Gestational age at laser surgery - wka 20.2 ± 3.0
Median Quintero stage (range) 2 (1-4)
Gestational age at birth - wka 33.9 ± 3.1
Female - no. (%) 55 (48%)
Vaginal delivery - no. (%) 80 (70%)
Birth weight - ga 2015 ± 678
a Value given as mean ± SD




impairment   (n = 19)
MDI < 2 SD 6 (32%)
PDI < 2 SD and CP - no. (%) 5 (26%)
PDI < 2 SD - no. (%) 4 (21%)
MDI < 2 SD, PDI < 2 SD and CP - no. (%) 2 (11%)
MDI < 2 SD, PDI < 2 SD and bilateral deafness - no. (%) 1 (5%)
CP - no. (%) 1 (5%)
MDI: mental development index; PDI: psychomotor development index; CP: cerebral palsy. 
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(n = 54)  
p-value 
Birth weight - ga 1773 ± 608 2076 ± 567 < 0.001
Weight at 2 years of age - kga 11.7 ± 1.3 12.3 ± 1.3 < 0.001
Length at 2 years of age - cma 86.8 ± 4.1 87.6 ± 3.8 0.005 
Head circumference at 2 years of 
age - cma
48.5 ± 1.4 48.9 ± 1.4 0.006
Cerebral palsy - no. (%) 3 (5%) 5 (9%) 0.25
Mental development indexa 96 ± 16 96 ± 18 0.90
Psychomotor development indexa 91 ± 13 89 ± 18 0.52
Neurodevelopmental impairmentb 
- no. (%)
10 (16%) 9 (17%) 1.0
a Value given as mean ± SD
b Neurodevelopmental impairment is defined as any of the following: cerebral palsy, 
 mental development index < 2 SD, psychomotor development index < 2 SD, bilateral 
 deafness or blindness.
Table 4 Mortality rate and adverse outcome (neurodevelopmental impairment or death) by 
Quintero stage of TTTS
TTTS stage Deatha Adverse outcomeb,c
I 6% (1/18) 6% (1/18)
II 29% (20/70) 40% (28/70)
III 36% (23/64) 52% (33/64)
IV 42% (5/12) 50% (6/12)
a Chi-square test for trend = 5.8, df = 1, p = 0.016 
b Chi-square test for trend = 9.2, df = 1, p = 0.002 
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Multiple logistic regression was carried out to measure the independent 
associations between neurodevelopmental impairment and various clinical 
parameters (gestational age at laser, gestational age at birth, birth weight, 
Quintero stage and donor versus recipient status).  We found a trend 
towards an independent association between higher Quintero stages and 
neurodevelopmental impairment (OR 6.6 for each stage, 95% CI 0.7 – 66.0, p = 
0.08) and lower gestational age at birth and neurodevelopmental impairment 
(OR 1.6 for each week, 95% CI 0.8 – 3.0, p = 0.08) (table 4).
Comment
The main objective of our study was to evaluate the long-term 
neurodevelopmental outcome in TTTS-survivors treated with fetoscopic laser 
surgery. We were able to follow-up all (100%) TTTS survivors and report a 
high incidence (17%) of neurodevelopmental impairment. The long-term 
neurolodevelopmental outcome found in this study is in agreement with the 
short-term neurological outcome reported previously by our research group, 
in which we found a similar incidence (14%) of severe cerebral lesions in TTTS-
survivors after laser treatment.12 
Four studies from three different research groups have reported on long-term 
outcome in TTTS after laser surgery. The incidence of neurodevelopmental 
impairment found in this study is somewhat higher than in these other reports. 
However, special care must be taken when comparing results from various 
studies, as discrepant results may partly be due to different methodology, 
selection criteria and definitions of neurodevelopmental impairment. De Lia 
et al report a 6% (6/93) incidence of severe handicaps in TTTS survivors after 
laser surgery.13 Mean age at follow-up was 14 months (range 1 to 34 months), 
which may be too soon for accurate assessment of CP or major developmental 
delay. Most importantly, the methods used to determine neurodevelopmental 
outcome were not specified, suggesting that accurate assessment of mental 
and psychomotor development was not performed. Sutcliffe et al found a 9% 
(6/66) incidence of CP in a cohort of TTTS survivors treated with laser.6 Follow-
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up was however incomplete (81%) and in 47% (31/66) of patients neurological 
outcome was assessed using information from the general practitioner. In 
the group assessed by a paediatrician, 14% (5/36) had CP. Children assessed 
by paediatricians were also tested with a standardized developmental test 
(Griffiths’ Developmental Test Scales). However, details on the number of 
infants with severe developmental delay (defined as a score < 2 SD) were not 
reported or scored as primary outcome, as opposed to the definition used 
in this study. The two largest follow-up cohorts have been reported by a 
research group from Germany. Using standardized developmental test and 
neurological examination, Banek et al and Graef et al report an incidence of 
major neurological deficiencies of 11% (10/89) and 6% (10/167) respectively.7;8 
In both studies, the definition of major neurological deficiencies did not include 
severe developmental delay. Therefore, as opposed to this study, infants with 
severe developmental delay but without CP were not included in the group with 
major abnormalities. Also, developmental outcome in the majority of children 
(112/167) in the study from Graef et al was only assessed by the Snijders-
Oomen Non-Verbal-Intelligence Test and therefore motor abilities were not 
tested. The incidence of CP in the studies from Banek et al and Graef et al, 
respectively 11% and 6%, was nevertheless similar to the 7% incidence of CP 
found in this study.
After treatment of TTTS with amniodrainage, most studies on long-term 
outcome report a high incidence of neurodevelopmental impairment, ranging 
from 22 to 26%.14-17 Only one study in TTTS treated with amniodrainage 
reported a lower incidence of CP or multicystic encephalomalacia of 7% (3/42), 
without assessment of neurodevelopmental delay.18 Overall, the reported 
incidence of neurodevelopmental impairment appears to be higher in TTTS 
survivors treated with serial amniodrainage than with laser surgery. However, 
different methodology may also explain the discrepancy in results between 
various follow-up studies. To assess the true difference in neurodevelopmental 
impairment in TTTS survivors treated with either laser surgery or serial 
amnioreduction, results of the long-term follow-up in the first randomized 
control trial comparing both treatments must be awaited.5
Absence of a control group is an important limitation of this study. A case-
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control study comparing the long-term outcome in monochorionic twins with 
TTTS treated with laser and monochorionic twins without TTTS is currently 
being performed at our institution.19
We found no difference in neurodevelopmental impairment between donor 
and recipient twins, suggesting that both are equally at risk for adverse 
neurodevelopmental outcome. These results are in agreement with previous 
studies.7;8;14 Donor twins are significantly smaller at birth than recipient 
twins, and remain smaller and shorter at 2 years of age. These findings are 
in agreement with previous reports.14 According to the ‘fetal origins of adult 
disease’ or ‘Barker hypothesis’, lower birth weight is associated with an 
increased risk for coronary heart disease, diabetes, hypertension and stroke 
in adulthood.20 Whether reduced birth weight in donor twins in TTTS may also 
lead to increased incidence of adult diseases is not known yet. 
Multivariate analysis showed a trend towards an independent association 
between neurodevelopmental impairment and lower gestational age at birth 
as well as higher Quintero stages. Prematurity is a well recognized risk factor 
for adverse neurodevelopmental outcome in twins as well as in singletons.21;22 
Although the prognostic value of Quintero stages is subject of debate, our 
results also suggest an important prognostic value of Quintero staging.4;23
The objective of fetal therapy should be to reach a high percentage of intact-
survival. Even though fetoscopic laser surgery appears to be the best available 
treatment option for TTTS, the idealistic goal of high intact-survival rate has 
not yet been reached. Timing of cerebral injury leading to neurodevelopmental 
impairment in TTTS treated with fetoscopic laser surgery is not clear. Cerebral 
Injury may occur before, during or after laser surgery. Therefore, whether 
cerebral injury and subsequent neurodevelopmental impairment could be 
prevented by advances in laser surgery techniques such as more selective or 
more complete coagulation of anastomoses, or by adaptation of inclusion 
criteria for laser surgery is not known. Considering the high incidence of 
adverse neurodevelopmental outcome in TTTS, we recommend that all 
surviving twins be thoroughly followed up.
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Abstract
Objective: In monoamniotic twin pregnancies discordant for fetal anomaly, 
parents may opt for selective feticide. However, the normal co-twin remains at 
risk of sudden demise from cord entanglement. We report on three cases of 
successful selective feticide by cord occlusion combined with cord transection.
Methods: We describe technical details and outcome of three monoamniotic 
twin pregnancies, discordant for fetal anomaly (two cases of anencephaly and 
one case of congenital heart block), in which cord occlusion was followed by 
transection of the cord, using contact laser. 
Results: The fetoscopic cord occlusion and transection, using laser, was 
successfully performed at 15, 16 and 19 weeks’ gestation, respectively. In one 
case, amniotic fluid leakage occurred after fetoscopy. The surviving co-twins 
were born healthy, two out three vaginally, at 36, 38 and 36 weeks’ gestation, 
respectively.
Conclusion: In monoamniotic twins, selective feticide using laser occlusion and 
transection of the umbilical cord is technically feasible and can lead to near-
term vaginal birth of healthy co-twins.
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Introduction
Monoamniotic twins occur in approximately 1% of monozygotic twin 
pregnancies. Monoamniotic twins are at increased risk of fetal anomalies, 
twin-to-twin transfusion syndrome (TTTS), fetal death and premature 
delivery. Perinatal mortality rates of 10-70% have been reported.1;2 
Entanglement and knots of the umbilical cords are the major cause of fetal 
death in monoamniotic twins.3 Cord entanglement is present in over 70% 
of monoamniotic twins, and is already seen in the first trimester.3;4 It is 
speculated that the occurrence and the fastening of knots occurs more 
easily when there is more amniotic fluid in relation to the fetal body masses. 
Several methods have been described that aim at lowering perinatal mortality 
from cord entanglement: reduction of amniotic fluid by amniodrainage, or 
administration of sulindac.5;6 Also, intensive inpatient fetal monitoring with 
elective preterm delivery has been described.6;7 Furthermore, congenital 
anomalies are found in 15-20% of monozygotic twin pregnancies, and may 
or may not be concordant.8 In case of congenital anomalies in one fetus 
of a monochorionic twin pair, the otherwise normal co-twin is at risk for 
in utero demise due to acute perimortem blood loss into the dying co-
twin.9 In addition, obstetric complications, due to the anomaly, for example 
polyhydramnios in pregnancies complicated by anencephaly, can present a 
threat to the normal co-twin. In twin pregnancies with one anomalous fetus, 
selective feticide can be indicated for two reasons, either to prevent the birth 
of a severely handicapped child, or to protect the normal co-twin against 
the described complications. Both in monochorionic and monoamniotic twin 
pregnancies, selective feticide should not be performed using fetal drug 
injection because of the presence of vascular anastomoses on the placental 
surface and the risk of acute hypovolaemia in the normal co-twin during 
demise of the anomalous twin. Therefore, umbilical cord occlusion is the 
method of choice.  However, after cord occlusion in monoamniotic twins, the 
incidence of cord accidents from entanglement and strangulation is still a 
serious threat, and reported to be as high as 36%.10 Therefore, transection of 
the occluded cord may be life saving for the normal co-twin.
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We report our experience with selective feticide using laser energy 
for occlusion and transection of the umbilical cord, in three cases of 
monoamniotic twins discordant for congenital anomalies.
Case 1
A 32-year-old woman was referred to our centre, which is the national 
referral centre for invasive fetal treatment in the Netherlands, at 14+1 weeks’ 
gestation, with a monoamniotic twin pregnancy complicated by one fetus with 
anencephaly. On ultrasound examination, the presence of anencephaly in one 
fetus was confirmed, the other fetus showed no signs of structural anomalies. 
Colour Doppler showed signs of cord entanglement. During counselling, 
consideration was given to the risk for the normal co-twin on the basis of cord 
entanglement, the risk of polyhydramnios with anencephaly and other known 
risks of monochorionic monoamniotic twinning. The couple opted for selective 
feticide of the anencephalic fetus. The procedure was performed at 15+4 
weeks’ gestation under general anaesthesia. A prophylactic dose of tocolytics 
(indomethacin) and antibiotics (amoxycillin/clavulanate) was given. An 18-
G needle was entered into the amniotic cavity under ultrasound guidance, 
followed by introduction of a 0.085-inch soft J-tipped guide wire (Cook®) 
through the needle using the Seldinger technique. A 10 F teflon cannula, 
loaded with a dilator, was advanced over the guide wire. When the cannula had 
entered the amniotic cavity, the quide wire and dilator were removed and the 
shaft loaded with the fetoscope (2 mm diameter) and laser fibre (400μm) was 
inserted. This procedure was also sonographically guided.
Amniotic fluid was blood stained, as is often the case in the presence of an 
anencephalic fetus. Amnioexchange with warm Ringers lactate was performed 
until a clear fluid compartment was reached. The umbilical cord of the 
abnormal fetus was identified and cord knots were present (Figure 1). 
Under fetoscopic sight and ultrasound guidance, the umbilical cord of the 
anencephalic fetus was coagulated by laser energy (Nd:YAG laser, Dornier 
Medizin Technik, Germering, Germany), close to the abdominal insertion 
of the umbilical cord, over a distance of 15 mm, using short bursts of 5-10 
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seconds, with a maximum power of 50 Watts. We aimed at whitening and 
shrinking the cord over a distance of 15 mm, as can be observed by direct 
visualisation, using the laser fibre (diameter 0.4 mm) as a reference, and also 
by sonographic measurement. Vascular occlusion was confirmed with colour 
Doppler ultrasound. Hereafter, the occluded cord was transected with the 
same laser fibre, set in the cutting mode (50 Watts). The procedure had an 
uneventful course. During the procedure, the normal fetus showed no changes 
in heart rate. Several weeks after the procedure, some leakage of amniotic 
fluid occurred. This leakage continued during pregnancy and resulted in 
oligohydramnios. Despite fluid leakage, the pregnancy continued uneventfully 
until the near term period. At 36+3 weeks’ gestation the woman went into 
labour and gave birth vaginally to a healthy boy weighing 3160 gram and a 5-
min Apgar score of 9. The neonatal course was uneventful.
Case 2
A 32-year-old woman, known with insulin-dependent diabetes mellitus, was 
referred to our hospital at 16+3 weeks’ gestation, with a monoamniotic 
twin pregnancy complicated by one fetus with anencephaly. On ultrasound 
examination the diagnosis of anencephaly was confirmed. On colour 
Doppler, signs of cord entanglement were present. The other fetus showed 
no structural anomalies. After counselling, the couple opted for selective 
feticide of the fetus with anencephaly. The procedure was performed at 16+4 
weeks’ gestation under general anaesthesia. A prophylactic dose of tocolytics 
(indomethacin) and antibiotics (amoxycillin/clavulanate) were given. The 
placenta covered the anterior uterine wall completely and, although very 
unusual even in anterior placenta, no placenta-free area could be identified 
for safe fetoscopic entry. Therefore, a midline laparotomy was performed. 
The uterus was gently exteriorised and an embryoscope (1 mm diameter) 
and laser fibre (400μm) were introduced through the posterior uterine wall 
into the amniotic cavity under ultrasound guidance. Amniotic fluid was 
clear. The umbilical cord of the abnormal fetus was identified. The presence 
of multiple complex cord knots was confirmed. Under embryoscopic sight 
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and ultrasound guidance, the umbilical cord of the anencephalic fetus was 
coagulated by laser energy, close to the abdominal insertion of the umbilical 
cord, over a distance of 15 mm, using short bursts of 5-10 seconds, with a 
maximum power of 30 Watts. Occlusion was confirmed with colour Doppler 
ultrasound. Hereafter, the occluded cord was transected with the laser fibre 
(400μm), set in the cutting mode (30 Watts). The procedure had an uneventful 
course. During the procedure, the normal fetus showed no changes in heart 
rate. Postoperative course was uneventful. At 37 weeks’ gestation the patient 
developed hypertension and episodes of hypoglycaemia. She was admitted to 
the referring hospital and ultrasound investigation showed macrosomia of the 
fetus. Labour was induced at 38 weeks’ gestation and a caesarean section was 
performed because of failure to progress. A healthy girl weighing 4044 gram 
was born. 
Case 3
A 33-year-old woman was referred to our hospital at 18+0 weeks’ gestation 
with a monoamniotic twin pregnancy complicated by one fetus with severe 
ventricular bradycardia of 47 beats per minute, due to a congenital heart 
block. Maternal serum tested negative for anti-SSA and anti-SSB antibodies. 
Diagnosis of congenital heart block was confirmed by fetal echocardiography. 
Cord entanglement with a complex knot was visible on ultrasound. The other 
fetus showed no anomalies. After extensive counselling, considering the risk 
of cardiac failure and death in the fetus with bradycardia and the subsequent 
risk for the other fetus, the couple opted for selective feticide of the fetus 
with the heart block. The procedure was performed at 18+6 weeks’ gestation 
under general anesthesia. The placenta was anterior, with a placenta-free 
window allowing safe percutaneous access. The same procedure as described 
in case 1 was followed. The amniotic fluid was clear. Once the umbilical cord 
insertion at the abdominal site of the fetus with the heart block was identified, 
it became clear that the entangled cords were too close to the abdominal wall 
of the fetus, making laser coagulation at this site unsafe. At the placental 
insertion site, the umbilical cords, with insertion close to each other, were free 
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Figure 1 Fetoscopic view of cord entanglement in a monoamniotic twin pregnancy.
Figure 2 Fetoscopic view of the occluded umbilical cord being transected using Nd:YAG laser 
energy through a 400 μm fibre in the cutting mode.
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of knots over a short distance of circa 5 cm. Using Doppler, the umbilical cord 
of the fetus with bradycardia could easily be identified, and was subsequently 
coagulated with laser energy and transected as described above (Figure 2). 
Figure 3 shows the cord insertion at the end of the operation. During the 
procedure, the normal fetus showed no changes in heart rate. The pregnancy 
proceeded uneventfully. At 35+6 weeks’ gestation, the patient was admitted to 
the referring hospital with premature rupture of membranes and contractions. 
A healthy girl was born vaginally, with a birth weight of 3100 gram and a 5-
min Apgar score of 9.
Discussion
Selective termination in twin pregnancies is to be considered as a management 
option in the presence of an anomaly in one fetus, severe enough either to lead 
to the birth of a severely handicapped child, or when it presents a threat to the 
normal co-twin e.g. by the development of polyhydramnios with risk of preterm 
birth. In monochorionic twin pregnancies, the placental anastomoses present a 
serious threat when one of the twins is critically ill or dying, because of acute 
perimortem TTTS.9 In case of a monoamniotic twin pregnancy, the risk of cord 
Figure 3 Fetoscopic view of the umbilical cord at the placental insertion after transection.
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entanglement and cord knots adds another major risk, even after the death of 
one fetus.10 
Selective feticide by cord occlusion has been widely accepted as a treatment 
option for monochorionic diamniotic twin pregnancies in case of discordant 
congenital anomaly, twin reversed arterial perfusion (TRAP) or severe TTTS 
with a critically ill fetus.11 In monoamniotic and pseudo monoamniotic twins, 
additional transection of the umbilical cord has been proposed, to avoid the 
complications of cord entanglement later in pregnancy.3;12-16 
Several techniques have been described to interrupt the blood flow in the 
umbilical cord. Percutaneous ultrasound-guided injection of thrombogenic 
material in the umbilical cord of an acardiac twin has been performed in 
various ways, e.g. trombogenic coils, fibrin superglue, or alcohol embedded 
suture.17-22 Unfortunately, this procedure has been associated with death 
of both twins in approximately half of the cases.18;19 The first described 
minimally invasive procedure using two 2-3 mm ports was umbilical cord 
ligation with a 3-0 Vicryl suture.23 Endoscopically guided photocoagulation 
of the cord using Nd:YAG laser through a single port was first described by 
Hecher et al.24 Ultrasound guided bipolar electro coagulation using a bipolar 
forceps through a 3 mm port was the next technique used for umbilical cord 
occlusion.14 In TRAP sequence, the treatment modality of choice is the so-
called intrafetal approach.25 
For transection of the occluded cord, some have proposed the use of scissors, 
others suggested using a harmonic scalpel via a single 5-mm port technique, 
or coaxial bipolar electrode (Versapoint®) via a two port technique (diameters 
3.8-mm and 2.2mm).12;13;15 In our three cases, a single port technique with 
a shaft containing a 2 mm fetoscope or 1 mm embryoscope with a 400 μm 
laser fibre was used. Under direct and continuous vision, coagulation was 
performed in the non-contact mode and the cord was transected in the 
contact mode. Laser occlusion of the umbilical cord has been described to 
be successful up to 20 weeks’ gestation.26 After 20 weeks, the thickness 
of the cord and the quantity of Wharton’s jelly content limit the effects of 
laser, and in these cases bipolar coagulation (followed by laser transection) is 
probably more successful.27 In monoamniotic twins with cord entanglement 
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and knots, the optimal identification site of the cord of the affected twin 
is at the abdominal insertion. Thus, the risk of coagulating the cord of the 
normal co-twin is small. Another advantage of coagulating the cord close to 
its abdominal insertion is the lack of mobility of the cord when touching it for 
the cutting session. In our three cases, the cord was easily transected and no 
technical complications occurred. In one case, ongoing amniotic fluid leakage 
occurred, a well-known complication of invasive fetal procedures. Because the 
risks associated with cord entanglement were ruled out by transecting the 
cord, near term vaginal birth was made possible. 
Conclusion
Laser coagulation and transection of the umbilical cord under direct vision 
is a minimally invasive single-port-technique that can be safely used for 
selective feticide in monoamniotic twin pregnancies with discordant congenital 
anomaly. 
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Abstract
Objective: To compare fetoscopic laser surgery with amniodrainage in the 
treatment of twin-to-twin transfusion syndrome (TTTS) diagnosed after 26 
weeks’ gestation. 
Methods: Treatment of TTTS consisted of either amniodrainage or fetoscopic 
laser coagulation of vascular anastomoses. Primary outcome was adverse 
outcome (intrauterine or neonatal death, major neonatal morbidity and/or 
severe cerebral injury). Secondary outcome was gestational age at birth.   
Results: Eleven TTTS cases were treated with amniodrainage and ten with laser 
surgery. Median gestational age at birth in the amniodrainage group and laser 
surgery group was 29 and 31 weeks respectively (p = 0.17) All infants were 
born alive. Major neonatal morbidity occurred more often in the amniodrainage 
group than in the laser surgery group, 27% (6/22) and 0% (0/20) respectively 
(p = 0.02). Severe cerebral injury in the amniodrainage group and laser surgery 
group occurred in 23% (5/22) and 15% (3/20) respectively (p = 0.70). Neonatal 
mortality in the amniodrainage group and laser surgery group was 14% (3/22) 
and 0% (0/20) respectively (p = 0.23). Overall adverse outcome was 36% (8/22) 
in the amniodrainage group and 15% (3/20) in the laser surgery group (p = 
0.17).
Conclusions: In TTTS diagnosed after 26 weeks’ gestation, amniodrainage and 
laser surgery both result in 100% survival. However, infants born after laser 
surgery have less major neonatal morbidity.
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Introduction
Monochorionic twin pregnancies are at risk for developing chronic twin-to-twin 
transfusion syndrome (TTTS) due to unbalanced inter-twin blood-flow through 
placental vascular anastomoses. TTTS may occur in 10-15% of monochorionic 
twin pregnancies, mostly in the second trimester of pregnancy.1
The first sonographic signs of TTTS are oliguria in the donor, resulting in 
oligohydramnios in the donor sac, and polyuria in the recipient, resulting in 
polyhydramnios and associated risks for preterm birth. Hereafter, more severe 
signs may occur such as anhydramnios in the donor twin, hydrops fetalis in the 
recipient twin, and eventually fetal demise. 
Serial amnioreduction has been the symptomatic treatment for TTTS for 
more than two decades. More recently, a cause-oriented approach for TTTS, 
fetoscopic laser coagulation of vascular anastomoses on the placental surface, 
was shown to result in significantly higher perinatal survival and improved 
neurological outcome.2 However, this randomised controlled trial and most 
other published studies on the treatment of TTTS with laser surgery were 
limited to pregnancies treated before 26 weeks’ gestation.2-4 
In monochorionic twin pregnancies, complicated by TTTS diagnosed after 
26 weeks’ gestation, apart from expectant management or amniodrainage, 
therapeutic delivery is a management option. In otherwise healthy fetuses, 
premature birth can lead to major handicaps, such as cerebral palsy, severe 
cognitive deficits and severe visual or hearing impairments. Neonates that have 
suffered from chronic TTTS in utero are known to have an additional risk on 
neurological morbidity, and other characteristic morbidities in TTTS, such as 
cardiovascular and renal morbidity.5-7 
The aim of this study was to evaluate the pregnancy and neonatal outcome in 
TTTS diagnosed after 26 weeks’ gestation in relation to treatment with either 
laser surgery or amniodrainage.
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Methods
All consecutive cases of monochorionic twins with chronic TTTS, diagnosed 
and treated after 26 weeks’ gestation at our centre between January 1991 
and February 2006 were included in the study. The Leiden University Medical 
Centre is the national referral centre for fetal therapy. During the study period, 
indications for treatment for TTTS were as follows: before August 2000, 
women with TTTS were routinely treated with amniodrainage. Amniodrainage 
was performed when chronic TTTS was diagnosed using standard prenatal 
ultrasound criteria: oligohydramnios (deepest vertical pocket ≤ 2cm) in the 
twin sac of one fetus and polyhydramnios (deepest vertical pocket ≥ 8cm 
before 20 weeks of gestation or ≥ 10cm after 20 weeks of gestation) in the 
twin sac of the other fetus.8 In August 2000 a fetoscopic laser surgery program 
for TTTS was started at our centre. Since then, women presenting between 
16 and 26 weeks‘ gestation with TTTS Quintero stage 1 and symptomatic 
polyhydramnios, or Quintero stages ≥ 2, were treated with laser surgery. After 
August 2000, amniodrainage and laser surgery, when technically feasible, 
were both discussed as options in case of TTTS Quintero ≥ 2. In Quintero stage 
1, or Quintero stage ≥ 2 with a completely anterior placenta, amniodrainage 
was performed. All procedures were sonographically guided. The fetoscopic 
laser surgery technique used was described in detail previously and is similar 
to the method reported by Hecher et al and Senat et al.2;4;9 To coagulate the 
anastomoses a Nd:YAG laser was used (Dornier Medizin Technik, Germering, 
Germany). The majority of fetoscopic procedures were performed under 
regional anaesthesia. A prophylactic dose of tocolytics (indomethacin) and 
antibiotics (amoxycillin/clavulanate) was given routinely. Amniodrainage was 
performed under continuous ultrasound guidance, using an 18 or 20 Gauge 
needle. Amniotic fluid was removed until deepest pocket was 6 cm. The 
procedure was repeated when clinical signs of maternal discomfort recurred. A 
prophylactic dose of tocolytics (indomethacin) was given routinely.
The following data were extracted from the medical records: gestational age 
at the time of diagnosis and treatment, Quintero stage prior to treatment, 
intrauterine fetal death, gestational age at delivery, and mode of delivery. 
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In the amnioreduction group we recorded the number of therapeutic 
amnioreductions and total volume of amniotic fluid removed. In the laser 
surgery group we recorded the total volume of amniotic fluid drained at 
the end of the laser procedure. In TTTS pregnancies treated after 1999, 
Quintero stage was assessed routinely prior to treatment.10 In pregnancies 
treated before 1999, Quintero stage was determined retrospectively for the 
purpose of this study. The following neonatal data were recorded: neonatal 
cranial ultrasound findings, chronic lung disease, symptomatic patent ductus 
arteriosus, necrotising enterocolitis, renal failure, hydrops fetalis, retinopathy 
of prematurity, anaemia at birth, polycythaemia-hyperviscosity syndrome 
requiring partial exchange transfusion and major congenital malformations. 
Haemoglobin levels were measured from umbilical cord blood. Anaemia at 
birth was defined as haemoglobin level below the 3rd percentile for gestational 
age requiring a blood transfusion during the first day of life. Cerebral 
ultrasound scans were performed in all neonates on the first day of life and 
thereafter according to our unit protocol. The cranial ultrasound protocol at 
our neonatal intensive care unit requires a minimum of 3 scans during the first 
week of life (day 1, 3 and 7), followed by at least 1 scan weekly until discharge. 
In term infants, repeat cranial ultrasound scans are not performed if scans are 
normal at birth. Severe cerebral injury on cranial ultrasound scans was defined 
as the presence of at least one of the following findings: intraventricular 
haemorrhage grade III, intraventricular haemorrhage with parenchymal 
involvement, cystic periventricular leucomalacia ≥ grade II, ventriculomegaly, 
porencephalic or parenchymal cysts or other major cerebral abnormalities 
associated with adverse neurological outcome, as previously described.11 Major 
neonatal morbidity was defined as any of the following: chronic lung disease, 
necrotising enterocolitis ≥ grade II, retinopathy of prematurity ≥ stage III, major 
cardiac morbidity requiring surgery or major ischemic limb injury, as previously 
described.12
The primary outcome was a composite outcome, adverse outcome, defined as 
intrauterine fetal demise, neonatal death, major neonatal morbidity or severe 
cerebral injury. Gestational age at birth was considered a secondary outcome. 
Outcome was compared between the amniodrainage and the laser surgery 
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group. Statistics: Results of categorical variables were compared using Fisher’s 
exact test. Unpaired Student’s t test was used to compare normally distributed 
values between two groups. Differences in Quintero stage, in gestational age at 
treatment and at birth, and in haemoglobin difference at birth were tested by 
Wilcoxon. A P-value of < 0 .05 was considered statistically significant. Statistical 
analysis was performed with SPSS version 11.0 (SPSS, Inc., Chicago, Illinois, 
USA).
Results
During the study period, 21 TTTS cases were diagnosed and treated after 
26 weeks’ gestation. Before August 2000, 4 TTTS cases were treated with 
amniodrainage after 26 weeks’ gestation. Between August 2000, when the laser 
program was started, and February 2006, 153 fetoscopic procedures for laser 
coagulation of vascular anastomoses for TTTS were performed. During this 
period, another 7 TTTS cases were treated with amniodrainage and 10 TTTS 
cases underwent laser surgery after 26 weeks’ gestation. 
In the amniodrainage group, Quintero stage 1, 2, 3 and 4 occurred in 4, 2, 
4 and 1 case, respectively. The median gestational age treatment was 27 
(range 26-29) weeks’ gestation. A mean of 1.6 (range 1-3) amniodrainage 
procedures was performed, 45% (5/11) of the women underwent more than 1 
amniodrainage procedure. Per amniodrainage procedure, a median amniotic 
fluid volume of 2000 ml (range 500-3500 ml) was removed.  
In the laser group, 2 cases had TTTS Quintero stage 2 and 8 cases had TTTS 
Quintero stage 3. The median gestational age treatment was 27 (range 26-28) 
weeks’ gestation. A median of 5 (range 2-10) anastomoses was coagulated. 
The maximum power used for coagulation was 70 Watts. At the end of the 
procedure, a median amniotic fluid volume of 1800 ml (range 0-4200 ml) was 
removed. The quality of chorionic plate exposure was good in all but one case, 
there were no difficulties with turbidity of amniotic fluid, and there was no 
need for amniotic fluid exchange to improve visualisation. Neither placental 
bleeding nor uterine bleeding occurred. In one case in the laser surgery group, 
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one amniodrainage procedure was performed three days before laser surgery. 
In another case in the laser surgery group, the procedure had to be abandoned 
because of poor visualisation, due to rapid leakage of amniotic fluid into the 
intraperitoneal cavity after severe vomiting of the patient. In a third case in 
the laser surgery group, after normalisation of the amniotic fluid in both sacs, 
the ex-recipient became severely anaemic and was treated with an intrauterine 
blood transfusion two weeks after laser surgery. Within 48 hours after the 
intrauterine transfusion, MCA-PSV Doppler studies showed again signs of 
severe fetal anaemia, cardiotocography demonstrated a sinusoidal pattern and 
a caesarean section was performed. This case has been described in detail, 
previously.13
Median gestational age at birth in the amniodrainage and laser surgery group 
was 29 and 31 weeks, respectively (p = 0.17). Median treatment-to-delivery 
interval in the amniodrainage and laser group was 9 and 31 days, respectively 
(p = 0.07). In the amniodrainage group, 9/11(82%) patients needed additional 
tocolysis for which a variety of drugs were used due to changing protocols 
including ritodrin, atosiban, indomethacin or nifedipin, versus 2/10(20%) in the 
laser surgery group (nifedipin) (p = 0.009). Steroids for fetal lung maturation 
were administered in 8/9(89%) and in 6/7(86%) of cases with premature birth < 
34 weeks, in the amniodrainage and in the laser surgery group, respectively (p 
= 1.0) Premature prelabour rupture of membranes (PPROM) < 2 weeks after the 
intervention occurred in 1/11 (9%) of the cases in the amniodrainage group and 
in none of the cases in the laser surgery group (p = 1.0). There were no intra-
uterine deaths, neither in the amniodrainage group, nor in the laser surgery 
group.
More then 25% birth weight discordance occurred in 2/11 (18%) of the 
amniodrainage group and in 2/10 (20%) of the laser surgery group. Major 
neonatal morbidity occurred only in the amniodrainage group (necrotising 
enterocolitis grade III, n =3, chronic lung disease, n = 2, terminal renal 
failure, n=1). Severe cerebral injury was diagnosed in 5 infants in the 
amniodrainage group (cystic periventricular leucomalacia ≥ grade II, n = 2, 
bilateral intraventricular haemorrhage grade III, n = 1, bilateral intraventricular 
haemorrhage with parenchymal involvement and post-haemorrhagic 
Chapter 8
125
Fetoscopic laser surgery for TTTS after 26 weeks’ gestation
ventricular dilatation, n =1, ventriculomegaly, n = 1) and in 3 infants in 
the laser group (ventriculomegaly, n = 1, porencephalic cyst, n = 1, middle 
cerebral artery infarction, n = 1). Neonatal death occurred in three infants 
in the amniodrainage group and was caused by terminal renal failure (n =1), 
bilateral intraventricular haemorrhage with parenchymal involvement and 
post-hemorrhagic ventricular dilatation (n = 1), and necrotising enterocolitis 
grade III (n = 1). Overall, adverse outcome in amniodrainage group and laser 
surgery group was 36% (8/22) and 15% (3/20), respectively (p = 0.17). Details 
on pregnancy outcome and neonatal outcome in the amniodrainage group and 
laser surgery group are reported in table 1.









Treatment to delivery interval – daysa 9 (0-65) 31 (5-75) 0.07
PPROM < 2 weeks after intervention – n (%) 1 (9) 0 (0) 1.0
Gestational age at birth – weeksa 29 (27-36) 31 (28-37) 0.17
Birth weight – grb 1472 ± 634 1615± 516 0.43
Haemoglobin difference at birth - g/da 4.0 (0.8-12.2) 1.2 (.0-16.6) 0.37
Anaemia at birth  - n (%) 2 (9) 4 (20) 0.40
Polycythaemia at birth - n (%) 3 (14) 1 (5) 0.61
Major neonatal morbidity - n (%) 6 (27) 0 (0) 0.02
Severe cerebral injury - n (%) 5 (23) 3 (15) 0.70
Neonatal death - n (%) 3 (14) 0 (0) 0.23
Adverse outcomec - n (%) (%) 8 (36) 3 (15) 0.17
a values given as median (range)
b values given as mean ±SD
c intrauterine fetal demise, neonatal death, major neonatal morbidity or severe cerebral injury
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Discussion
In this study we found that in TTTS diagnosed after 26 weeks’ gestation, 
treatment with laser surgery was associated with a trend towards higher 
gestational age at birth and a longer treatment-to-delivery interval, and 
with significantly less major neonatal morbidity than in TTTS treated with 
amnioreduction. Neonatal morbidity such as necrotising enterocolitis 
and chronic lung disease are known to be directly related to prematurity, 
suggesting a direct relationship between the lower gestational age at birth in 
the amnioreduction group and the higher rate of major neonatal morbidity. 
Severe cerebral injury was similar in the laser group and amnioreduction group. 
As previously reported, the majority of cerebral injury in TTTS is of antenatal 
origin.11;14-16  This may explain why TTTS survivors treated with laser surgery 
in this study do not have a lower incidence of severe cerebral injury despite the 
more advanced gestational age at birth. Overall, we found a trend towards less 
adverse outcome in TTTS treated with laser as compared with amnioreduction, 
but numbers were probably too small to reach significance. For a randomised 
controlled trial comparing amnioreduction with laser after 26 weeks’ gestation 
with a power of 0.80, a total of 126 patients, 63 in each arm would be needed 
to show that the expected reduction in adverse outcome from 36% to 15% is 
statistically significant. 
In severe second trimester TTTS, because of the poor survival rates with 
conservative management, there is general consensus that therapy should be 
offered. Fetoscopic laser coagulation of vascular anastomoses on the placental 
surface is associated with significantly higher perinatal survival and improved 
neurological outcome as compared with serial amioreduction2. However, 
most published series of TTTS cases treated with laser surgery are limited to 
gestational ages under 26 weeks.2;4;17;18 Only one case series included patients 
until 28 weeks’ gestation.19 To our knowledge, no specific details on neonatal 
outcome after laser surgery or amniodrainage for TTTS performed after 26 
weeks’ gestation have yet been reported.
When TTTS occurs after 26 weeks’ gestation, common advice for management 
is either to perform one or more amniodrainages or, in selected cases of severe 
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TTTS, preterm delivery. Both options are associated with a significant risk of 
neonatal death or major neurological sequelae, either due to problems related 
to the invasive nature of the procedure with inherent risks of premature birth, 
or to TTTS itself.20-22 Laser surgery is usually not advocated as the treatment of 
choice in early third trimester TTTS, possibly because of the expected higher 
rate of complications such as premature rupture of membranes as compared 
with amniodrainage. Our preliminary data show that new consideration should 
be given to laser surgery as a valid alternative to amniodrainage in early third 
trimester TTTS. 
Performing a successful uncomplicated laser procedure allows the fetuses to 
recover from TTTS in utero and results in more advanced gestational age at 
birth. Selection of the cases at minimal risk of complications is an important, 
but difficult issue. Placental localisation, and in particular anterior placental 
localisation, is an important issue in fetoscopic laser surgery. In this non-
randomised descriptive study, placental localisation was mainly posterior (7 
cases), or anterior with a placenta free window for lateral percutaneous access 
(3 cases). In this selected group of cases laser surgery was feasible. Obviously, 
due to the retrospective character of this study, our results are subjected to a 
selection bias. Another important, but inevitable limitation of this study is the 
small number of cases. In order to determine the best management of early 
third trimester TTTS, further studies are urgently needed. Considering the low 
incidence of TTTS presenting after 26 weeks’ gestation, the ideal setting of 
such a study would be a sufficiently large multi-centre randomised study. 
Conclusion
In this study, less major neonatal morbidity occurred in TTTS cases, diagnosed 
and treated after 26 weeks’ gestation as compared with amniodrainage. 
This finding suggests that fetoscopic laser surgery is a valid alternative to 
amniodrainage in the treatment of TTTS after 26 weeks. 
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General discussion and future perspectives
In monochorionic twin pregnancies, the fetuses share a common placenta with 
vascular anastomoses between both circulations and have a significantly higher 
risk of adverse outcome than dichorionic twins and singletons. Complications 
in monochorionic twin gestation include twin-to-twin transfusion syndrome 
(TTTS), severe intrauterine growth retardation (IUGR), twin reversed arterial 
perfusion (TRAP), increased rate of fetal anomalies, and death of the co-twin. In 
the case of single intrauterine fetal demise in monochorionic twin pregnancies, 
the vascular anastomoses allow the transfer of blood from the surviving twin to 
the dead twin, the so-called acute perimortem intertwin transfusion, which can 
lead to periods of hypoperfusion, hypotension, acute fetal anaemia, eventually 
resulting in co-twin demise and neurologic abnormality in the surviving co-twin. 
In the last decades, important advances have been made in fetoscopic 
treatment. However, few of these interventions are evidence-based, and many 
questions remain to be answered. These questions pertain to type and timing 
of treatment in TTTS and severe discordant IUGR, and to the prevention of 
PROM after fetoscopic interventions.
TTTS
Today, laser surgery is considered to be the first choice of treatment for severe 
TTTS between 16 and 26 weeks’ gestation.1 There is still debate, however, on 
whether and how to treat TTTS Quintero stage 1. In contrast to Quintero et 
al, who reported that stage is not an important prognostic factor when laser 
therapy is involved, we found that the earlier the Quintero stage at the time of 
treatment, the better the outcome (Chapter 3).2 Our findings are in accordance 
with the results of a randomised study reporting significantly better perinatal 
outcome of fetoscopic laser surgery in Quintero stages 1 and 2 as compared 
to stages 3 and 4; our findings also agreed with the results published by 
Huber et al, who reported a significant trend toward reduced survival rates 
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after treatment with laser surgery for fetuses at later Quintero stages.1;3 These 
findings support the hypothesis that laser surgery should be the first choice of 
treatment, even in early Quintero stages.
There is controversy about the best way to manage TTTS diagnosed early in the 
3rd trimester. Apart from expectant management or amniodrainage, elective 
delivery is an option. In otherwise healthy fetuses, premature birth can lead to 
major handicaps, such as cerebral palsy, severe cognitive deficits, and severe 
visual or hearing impairments. Neonates that have suffered from chronic TTTS 
in utero are known to have an additional risk of neurological morbidity, and 
other characteristic morbidities in TTTS, such as cardiovascular and renal 
morbidity.5-7 Laser surgery is usually not advocated as the treatment of choice 
in early third trimester TTTS, possibly because of the expected higher rate of 
complications compared with amniodrainage, including premature rupture 
of membranes. The preliminary data described in this thesis (Chapter 8), 
comparing amniodrainage and laser surgery for treatment of TTTS diagnosed 
after 26 weeks’ gestation, shows that laser surgery should be considered as 
a valid alternative to amniodrainage in early third trimester TTTS. In order to 
determine the best way to manage early third trimester TTTS, further studies 
are urgently needed. Considering the low incidence of TTTS appearing after 26 
weeks’ gestation, the ideal setting of such a study would be a sufficiently large, 
multi-centre randomised study.
Incomplete laser surgery and residual anastomoses do not necessarily result 
in recurrence or reversal of TTTS (see Chapter 4). Recently, an atypical form of 
chronic TTTS has been described, the so-called twin anaemia-polycythaemia 
sequence.7 This phenomenon occurs in the absence of a twin oligo-
polyhydramnios sequence (TOPS) and therefore does not fulfill the criteria of 
TTTS. In the reported cases, placental injection studies revealed the presence 
of very small (<1 mm) uni-directional arterio-venous anastomoses. Robyr et 
al also reported that TAPS developed after incomplete laser surgery, in 13 of 
101 TTTS cases, and Lewi et al reported it in 4 of 43 TTTS cases with double 




whereas the former donor became polycythaemic. Treatment options include 
expectant management, re-intervention with laser coagulation of the residual 
vascular anastomoses, feticide by cord coagulation, intrauterine transfusion, 
and elective delivery when appropriate. Expectant management carries the 
risk of the anaemic fetus developing hydrops, followed by intra-uterine death. 
Re-intervention incurs both procedure-related risks and the risk of operative 
failure as a result of the inability to identify the residual anastomoses due to 
their small diameter. Because of ongoing fetofetal transfusion, intra-uterine 
transfusion only gives a temporary rise of the anaemic fetus’ hemoglobine 
count, and it exposes the polycythaemic fetus to the risk that polycythaemia-
hyperviscosity syndrome will be aggravated, which is known to be a risk factor 
for necrotic tissue injury and gangrene.10;11 However, since it is not certain 
whether TAPS is associated with increased morbidity or mortality, the question 
whether and how to treat it still needs to be clarified.
Severe discordant IUGR
The distinction between TTTS and IUGR is based on the absence of 
polyhydramnios in the sac of the appropriately grown fetus in discordant 
IUGR. Birth weight discordance carries a greater risk of complications in 
monochorionic twin pregnancies than in dichorionic ones because of the 
vascular anastomoses on the placental surface. 
Several studies have reported on perinatal outcome of monochorionic 
pregnancies complicated by discordant growth retardation. Gratacos et al 
reported that the presence of intermittently absent or reversed end diastolic 
flow in the umbilical artery in monochorionic twins with selective IUGR, 
identifies a subgroup with an elevated risk of intrauterine demise of the 
smaller twin and neurological damage in the larger twin, the latter even in 
the case where the smaller co-twin survives.12 Another study showed that 
monochorionic infants had a seven-fold higher incidence of cerebral white 
matter lesions than dichorionic infants.13 Discordant birth weight, TTTS, 
and being a survivor after co-twin demise were independent risk factors 
136
Chapter 9 General discussion
for cerebral white matter lesions. Huber et al concluded that amniotic fluid 
discordance in monochorionic diamniotic twin pregnancies in combination 
with IUGR and absent or reversed end diastolic flow in the umbilical artery 
in one fetus represents an extremely high-risk constellation for adverse 
pregnancy outcome.14 This raises the question whether an intervention could 
optimise outcome. Treatment options are expectant management, fetoscopic 
laser coagulation of vascular anastomoses, umbilical cord ligation of the 
growth-retarded fetus, or elective delivery when appropriate. The risks of 
expectant management have been described above. Fetoscopic laser surgery 
aims to “bichorionise” the monochorionic twin pair, after which nature can 
follow its course without risk of adverse effects on the normal co-twin in 
case the condition of the growth-retarded fetus deteriorates. However, in the 
absence of severe oligo-polyhydramnios sequence, fetoscopic laser surgery 
is a technical challenge, with the potential risk of impaired visualisation and 
inability to identify and coagulate all anastomoses, as well as possibly requiring 
excessive amnion infusion. When performing umbilical cord ligation of the 
growth-retarded fetus, fetoscopic entry is preferably via the sac of this fetus 
without perforating the intertwin membrane, but severe oligohydramnios may 
prevent optimal fetoscopic entry. Moreover, the decision to perform umbilical 
cord ligation puts the parents in the difficult emotional situation, where they 
have to choose to give up on one child in order to save the other. Quintero 
et al suggested that a trial of laser surgery versus expectant management is 
indicated in monochorionic twins with highly discordant intrauterine growth 
restriction, and such a randomised trial is currently being conducted in the 
United States.15
Rupture of the fetal membranes after fetoscopic interventions
One of the major problems associated with invasive procedures is the risk of 
“iatrogenic” preterm prelabour rupture of membranes (iPPROM). Subclinical 
amniotic fluid leakage in the immediate postoperative period probably occurs 




relevant it is called iPPROM.16;17 Within 1 week of intervention, 7% of fetoscopic 
laser procedures for TTTS are complicated by iPPROM.18 For more complex 
fetoscopic procedures, the risk can be up to 30%.19 Since most invasive 
procedures are performed in the second trimester of pregnancy, iPPROM 
usually occurs at an early gestational age, with important fetal consequences 
(perinatal mortality and morbidity) and maternal ones (chorioamnionitis). This, 
of course, limits the clinical use of the fetoscopic technique and is a major 
obstacle for further development. It is important to develop strategies to seal 
the membrane defect or stimulate the repair mechanisms of fetal membranes 
at the time of the procedure. In the last six years, several (case) reports have 
been published on fetal membrane sealing strategies after iPPROM. In a series 
of 22 cases, Quintero et al describe 8 cases with iPPROM and 14 cases with 
amnion-chorion dissociation after amniocentesis or fetoscopy between 16 
and 24 weeks’ gestation.20 As an experimental treatment, the uterine cavity 
was punctured with a 22 Gauge needle, and various volumes of platelets and 
cryoprecipitate were injected intra-amniotically. Using this “amnion-patch” 
technique, the amniotic fluid leakage stopped in 9 cases, and 18 of 32 fetuses 
survived (56%). However, 2 cases were complicated by sudden intrauterine 
fetal death, possibly as a result of severe haemodynamic changes induced by 
platelet activation. These serious complications stress the need for further 
research to develop strategies and regimens to heal defects in the fetal 
membranes after iPPROM.21 In the meantime, every indication for fetoscopic 
surgery should be carefully weighed by an experienced team. During fetoscopic 
procedures, the best means of preventing iPPROM is by reducing the size and 
number of uterine entry ports.
Important advances have been made in the field of fetoscopic fetal therapy 
during the past decade. However, untimely treatment and pregnancy and 
neonatal complications still occur frequently. More research and new 
developments are required to further improve fetoscopic techniques and to 
further reduce complications.
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Leiden University Medical Centre (LUMC) is a tertiary medical centre in the 
Netherlands and serves as the national referral centre for fetal therapy. Since 
august 2000, when the fetoscopic surgery program was started, several study 
projects on endoscopic fetal surgery were initiated in close collaboration 
with the neonatology division of the paediatrics department at LUMC. In this 
thesis, studies on fetoscopic interventions in complicated monochorionic twin 
pregnancies are presented.
Chapter 1 is a brief introduction concerning the characteristics of 
monochorionic twin pregnancies. The major complications of monochorionic 
twin gestation, twin-to-twin transfusion syndrome (TTTS), severe intrauterine 
growth retardation (IUGR), increased rate of fetal anomalies, death of the co-
twin, and the various therapeutic options are discussed. 
In Chapter 2 we assessed the value of serial ultrasound examinations in 
combination with patient instructions, to report the onset of symptoms, 
for timely detection of TTTS in a cohort of monochorionic diamniotic twin 
pregnancies. Timely detection of TTTS was defined as diagnosis before severe 
complications of TTTS, such as preterm prelabour rupture of membranes, very 
preterm delivery (24-32 weeks of pregnancy), fetal hydrops, or intrauterine 
fetal death occurred. Ultrasound and Doppler measurements (nuchal 
translucency thickness, presence of membrane folding, estimated fetal weight, 
deepest vertical pocket, bladder filling, and Doppler waveforms of the umbilical 
artery, ductus venosus, and umbilical vein) were performed at least every 
2 weeks. A prospective series of 23 monochorionic twin pregnancies was 
monitored from the first trimester until delivery. Measurements of TTTS cases 
were compared with those of non-TTTS cases matched for gestational age. 
Furthermore, patients were informed about the symptoms caused by TTTS, and 
instructed to consult us immediately in case of rapidly increasing abdominal 
size or premature contractions. During the study period, 4 cases of TTTS 
were diagnosed. In all these cases, the diagnosis was timely (one case was at 
Quintero Stage 1, two at Quintero Stage 2, and one at Quintero Stage 3).Two of 
the TTTS cases became apparent after the patients’ feeling of rapidly increasing 
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girth. The identification of TTTS predictors was successful with respect to one 
parameter: isolated polyhydramnios in one sac, without oligohydramnios in 
the other, preceded the ultimate diagnosis of TTTS in two of the four TTTS 
cases. All other ultrasound measurements of TTTS cases, prior to the diagnosis 
of TTTS, were within the range of measurements of non-TTTS cases. We 
concluded that biweekly ultrasound examinations, with special attention to 
amniotic fluid compartments of both fetuses, combined with detailed patient 
instructions to report the onset of symptoms resulted in timely diagnosis of all 
TTTS cases and appears to be a safe program for monitoring monochorionic 
twin pregnancies.
Since August 2000, in the LUMC, fetoscopic laser surgery has been the 
preferred treatment modality for TTTS. In Chapter 3 we evaluated the 
results of the first 100 consecutive pregnancies with severe second 
trimester TTTS treated with selective fetoscopic laser coagulation of 
vascular anastomoses on the placental surface at our centre. Perinatal 
survival was analysed in relation to Quintero stage at the time of 
treatment.
The median gestational age at fetoscopy was 20 weeks (range 16-26), and 
the median gestation age at delivery was 33 weeks (range 18-40). Perinatal 
survival rate was 70% (139/200). The treatment resulted in at least one 
survivor at the age of 4 weeks in 81% of pregnancies. Perinatal survival was 
significantly higher when treatment was performed in the early Quintero 
stages (95% in stage 1, 76% in stage 2, 70% in stage 3, 50% in stage 4) 
(p=0.02). We concluded that the initial results of fetoscopic laser surgery 
for TTTS in our centre were similar to those in specialised centres in other 
countries. Diagnosis and treatment in the early Quintero stages resulted in 
significantly higher perinatal survival.
In Chapter 4 the frequency of residual placental vascular anastomoses 
after fetoscopic laser surgery for TTTS was studied. Presence of residual 
anastomoses was studied in association with adverse outcome and inter-twin 




or severe cerebral injury) was similar in the groups with and without residual 
anastomoses, 18% (6/34) and 29% (20/70) respectively (p = 0.23). Large inter-
twin hemoglobin differences (> 5 g/dL) were found in 65% (11/17) of cases with 
residual anastomoses and 20% (7/35) of cases without residual anastomoses (p 
< 0.01). Anterior placental localization was not associated with a more frequent 
presence of residual anastomoses. The first conclusion of this study is that 
laser treatment needs to be improved, as only 2/3 of monochorionic placentas 
are functionally ”bichorionised”. The second conclusion is that residual 
anastomoses in this study are not associated with adverse outcome. Lack of 
association between residual anastomoses and adverse outcome may be partly 
due to the small size of most residual anastomoses (<1mm diameter in 64% 
of the cases) and the presence of “protective” residual superficial anastomoses 
in 35% of the cases. Finally, we conclude that residual anastomoses are often 
associated with haematological complications in the neonatal period.
In patients with placental localisation on the posterior wall of the uterus, 
percutaneous insertion of the fetoscope for laser coagulation gives 
perpendicular access to the chorionic plate and the vascular anastomoses on 
its surface, and is, in experienced hands, a straightforward procedure. An 
angle of approximately 90 degrees between chorionic plate and fetoscope 
and laser fibre provides maximal visualisation of the vascular equator and 
optimal laser effectiveness. An anterior placenta, however, presents a technical 
challenge, because perpendicular access is not possible. In Chapter 5 we 
describe a novel technique for fetoscopy in TTTS with completely anterior 
placenta where laparoscopy is used to guide safe percutaneous insertion of the 
fetoscope through the lateral abdominal wall and the dorsal side of the uterus. 
We compared 16 TTTS pregnancies with completely anterior placenta (study 
group) treated with this novel technique with 49 TTTS pregnancies treated 
with conventional percutaneous fetoscopic laser without laparoscopy: 9 of 
these with partially anterior placenta (control group A) and 40 with lateral or 
posterior placenta (control group B). In the study group, the procedure-related 
complication rate was 25% (4/16). In one case uterine entry of the fetoscope 
from the lateral abdominal wall was not possible due to complex bowel 
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adhesions. In 3 patients, intraamniotic haemorrhage occurred after fetoscopic 
entry, preventing complete laser coagulation of anastomoses. One of these 
patients required two units of blood transfusion. The procedure-related 
complication rate in control group A and B was 22% (2/9) and 5% (2/40), 
respectively (intraamniotic haemorrhage n =3, severe leakage of amniotic fluid 
into the peritoneal cavity, n=1). Perinatal survival in the study group, control 
group A and control group B was 63% (20/32), 78% (14/18) and 70% (56/80), 
respectively. We concluded that combined laparoscopy and fetoscopy is a novel 
technique that enables safe uterine entry and creates optimal visualisation 
for laser coagulation of inter-twin anastomoses in TTTS pregnancies with 
completely anterior placenta. Procedure-related complication rate and 
perinatal survival rate were similar compared to the conventional percutaneous 
technique. Procedure-related complications occur more often with partially or 
completely anterior placenta.
Chapter 6 describes the long-term neurodevelopmental outcome in TTTS 
treated with fetoscopic laser surgery. All TTTS cases treated consecutively 
at our centre between August 2000 and December 2003 were included in 
the study. Perinatal mortality was 30% (49/164). Neurological, mental and 
psychomotor development at 2 years for age was assessed in all TTTS survivors 
(n = 115). Overall, the incidence of neurodevelopmental impairment was 17% 
(19/115) and was due to cerebral palsy (n = 8), severe mental developmental 
delay (n = 9), severe psychomotor developmental delay (n = 12) and deafness 
(n = 1). From this long-term follow-up study, we concluded that the incidence 
of neurodevelopmental impairment in TTTS survivors, treated with fetoscopic 
laser surgery, is high and warrants long-term follow-up.
In monoamniotic twin pregnancies discordant for fetal anomaly, parents 
may opt for selective feticide by umbilical cord coagulation. However, the 
normal co-twin remains at risk of sudden demise from cord entanglement. 
In Chapter 7 we report on three cases of successful selective feticide by 
cord occlusion combined with cord transection to prevent complications 




monoamniotic twin pregnancies, discordant for fetal anomaly (two cases of 
anencephaly and one case of congenital heart block), in which cord occlusion 
was followed by transection of the cord, using contact laser. The fetoscopic 
cord occlusion and transection, using laser, was successfully performed at 15, 
16 and 19 weeks’ gestation, respectively. In one case, amniotic fluid leakage 
occurred after fetoscopy. The surviving co-twins were born healthy, two out 
three vaginally, at 36, 38 and 36 weeks’ gestation, respectively. We concluded 
that in monoamniotic twins, selective feticide using laser occlusion and 
transection of the umbilical cord is technically feasible and can lead to near-
term vaginal birth of healthy co-twins.
In monochorionic twin pregnancies, complicated by TTTS diagnosed after 
26 weeks’ gestation, apart from expectant management or amniodrainage, 
therapeutic delivery is a management option. In otherwise healthy fetuses, 
however, premature birth can lead to major handicaps, such as cerebral palsy, 
severe cognitive deficits and severe visual or hearing impairments. Neonates 
that have suffered from chronic TTTS in utero are known to have an additional 
risk of neurological morbidity, and other characteristic morbidities in TTTS, 
such as cardiovascular and renal morbidity. In Chapter 8 we retrospectively 
studied 21 TTTS cases, diagnosed after 26 weeks’ gestation, and treated in the 
Leiden University Medical Centre between January 1991 and February 2006 with 
either amniodrainage or fetoscopic laser surgery. Main outcome measures were 
adverse outcome (intrauterine or neonatal death, major neonatal morbidity 
and/or severe cerebral injury) and gestational age at birth. Eleven TTTS cases 
were treated with amniodrainage and ten with laser surgery. Median gestational 
age at birth in the amniodrainage group and laser surgery group was 29 and 
31 weeks respectively (p = 0.17) All infants were born alive. Major neonatal 
morbidity occurred more often in the amniodrainage group than in the laser 
surgery group, 27% (6/22) and 0% (0/20) respectively (p = 0.02). Severe 
cerebral injury in the amniodrainage group and laser surgery group occurred 
in 23% (5/22) and 15% (3/20) respectively (p = 0.70). Neonatal mortality in 
the amniodrainage group and laser surgery group was 14% (3/22) and 0% 
(0/20) respectively (p = 0.23). Overall adverse outcome was 36% (8/22) in the 
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amniodrainage group and 15% (3/20) in the laser surgery group (p = 0.17). We 
concluded, that in TTTS diagnosed after 26 weeks’ gestation, amniodrainage 
and laser surgery both result in 100% survival. However, the incidence of major 
neonatal morbidity in infants born after laser surgery was lower. Our findings 
suggest that even in TTTS diagnosed after 26 weeks’ gestation laser surgery 
should be considered.
In conclusion, although important advances have been made in the field of 
fetoscopic fetal therapy during the past decade, untimely treatment and severe 
perinatal complications still do occur very frequently. More research and new 







Hoofdstuk 1 bevat een korte inleiding over eeneiige tweelingzwangerschappen 
en de daarbij voorkomende problemen. Ongeveer 1-2% van alle 
zwangerschappen zijn tweelingzwangerschappen. Er zijn twee soorten 
tweelingen: eeneiige en twee-eiige. Ongeveer tweederde van de tweelingen is 
twee-eiig en ongeveer eenderde is eeneiig. Alle twee-eiige tweelingen hebben 
een eigen placenta (dichoriaal). Van de eeneiige tweelingen heeft ongeveer 30% 
ieder een eigen placenta, maar 70% deelt samen één placenta (monochoriaal). 
Wanneer de tweeling wel de placenta deelt, maar de kinderen ieder in een 
eigen vruchtzak zitten, noemen we dit een monochoriale diamniotische 
tweelingzwangerschap. In zeldzame gevallen, namelijk in 1-2% van de 
monochoriale tweelingzwangerschappen, bevinden de twee kinderen zich 
samen in één vruchtzak en spreken we van een monochoriale monoamniotische 
tweelingzwangerschap. In tegenstelling tot bij dichoriale placenta’s zijn 
op monochoriale placenta’s vrijwel altijd vaatverbindingen, vasculaire 
anastomosen, aanwezig. Via deze anastomosen staat de bloedsomloop 
(circulatie) van het ene kind in verbinding met de circulatie van het andere 
kind. De vasculaire anastomosen zijn een belangrijke oorzaak van ziekte en 
sterfte (morbiditeit en mortaliteit), in de zwangerschap of rondom de geboorte, 
bij monochoriale tweelingzwangerschappen. De belangrijkste problemen van 
monochoriale tweelingzwangerschappen zijn het tweeling-transfusie syndroom 
(TTS), intra-uteriene groeivertraging (IUGR) en aangeboren afwijkingen bij één 
van beide kinderen. Wanneer als gevolg van een dergelijke complicatie één van 
beide kinderen in de baarmoeder overlijdt, ontstaat een levensbedreigende 
situatie voor het andere kind. Als gevolg van het wegvallen van de bloeddruk 
bij het overleden kind, kan het overlevende kind via de anastomosen veel bloed 
verliezen in de circulatie van het overleden kind en als gevolg daarvan zelf 
komen te overlijden of hersenschade oplopen.
TTS treedt op in 15% van de monochoriale zwangerschappen, meestal tussen 
een zwangerschapsduur van 16 en 26 weken. Hierbij krijgt één kind te veel 
bloed (de recipiënt) terwijl de andere te weinig krijgt (de donor). De recipiënt 
gaat veel plassen, waardoor de hoeveelheid vruchtwater enorm toeneemt 
(polyhydramnion), terwijl de donor steeds minder gaat plassen en steeds 
minder vruchtwater overhoudt (oligohydramnion). Het polyhydramnion kan 
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de oorzaak zijn van vroegtijdige weeën en vroeggeboorte met een zeer 
hoog risico op morbiditeit en mortaliteit. Aanvankelijk werd TTS behandeld 
door herhaaldelijk de overmaat aan vruchtwater bij de recipiënt af te tappen 
om zo de vroeggeboorte te voorkomen (amniodrainage). De oorzaak van 
het ziektebeeld werd hierbij echter niet behandeld. Begin jaren ’90 werd in 
de Verenigde Staten een oorzakelijke behandeling voor TTS uitgevonden: 
de foetoscopische laserbehandeling. Hierbij wordt een kijkbuisje in de 
baarmoederholte gebracht en worden de anastomosen op de placenta 
opgespoord. Vervolgens worden deze anastomosen met behulp van laserlicht 
dichtgeschroeid (gecoaguleerd). Op deze manier worden de circulaties van 
de kinderen van elkaar gescheiden en kunnen de kinderen zich herstellen 
van het tweeling-transfusie syndroom, omdat de oorzaak van TTS hiermee is 
weggenomen.
Bij ernstige IUGR of aangeboren afwijkingen van één van beide kinderen bestaat 
kans op sterfte van het te kleine of afwijkende kind. Om het gezonde kind te 
beschermen tegen de nadelige gevolgen van het overlijden van het zieke kind, 
kan overwogen worden ook in deze gevallen de bloedsomlopen van elkaar te 
scheiden. Dit kan door dezelfde foetoscopische laserbehandeling; immers door 
het dichtmaken van de anastomosen zijn de foetale circulaties gescheiden 
en kan het gezonde kind geen nadelige gevolgen meer ondervinden in geval 
van overlijden van het zieke kind. Een andere manier om de circulaties van 
elkaar te scheiden is het dichtmaken van de bloedvaten in de navelstreng 
(navelstrengcoagulatie). Wanneer één kind van een monochoriale tweeling 
ernstige aangeboren afwijkingen heeft met een zeer slechte prognose, kan 
besloten worden tot een navelstrengcoagulatie van dit kind. Als gevolg 
hiervan zal het zieke kind direct overlijden, maar dit brengt dan geen gevaren 
met zich mee voor het overlevende kind. In geval van ernstige IUGR van één 
van beide kinderen is nog onbekend welk beleid het beste is, afwachten of 
laserbehandeling/navelstrengcoagulatie. 
Het Leids Universitair Medisch Centrum (LUMC) is een centrum voor 
derdelijns obstetrische pathologie en is het nationale verwijzingscentrum 
voor behandelingen van een ziek kind (of zieke kinderen) in de baarmoeder 




LUMC de foetoscopische laser behandeling in gecompliceerde eeneiige 
tweelingzwangerschappen toegepast. Sindsdien werden bijna 250 
foetoscopische ingrepen verricht. In dit proefschrift wordt het resultaat 
van een aantal studieprojecten beschreven, die werden uitgevoerd in een 
nauw samenwerkingsverband tussen de afdeling verloskunde en de afdeling 
neonatologie van het LUMC.
In Hoofdstuk 2 hebben wij onderzocht wat de waarde is van tweewekelijks 
echo-onderzoek, samen met het geven van instructies aan de patiënt om 
vroege symptomen direct te rapporteren, ten aanzien van het tijdig stellen 
van de diagnose TTS in een cohort monochoriale tweelingzwangerschappen. 
Tevens evalueerden we welke echografische bevindingen voorspellend 
waren voor het optreden van TTS. Tijdig stellen van de diagnose TTS werd 
gedefinieerd als het stellen van de diagnose voordat ernstige complicaties van 
TTS optraden, zoals voortijdig breken van de vliezen, ernstige vroeggeboorte 
(24-32 weken zwangerschapsduur), hydrops foetalis, of intra-uteriene 
vruchtdood. Echo-onderzoek werd minstens eens per twee weken verricht 
(nekplooimeting, aanwezigheid van “membrane folding”, geschat foetaal 
gewicht, diepste verticale vruchtwater pocket, blaasvulling, en Doppler flow 
metingen van de arteria umbilicalis, ductus venosus en vena umbilicalis). 23 
eeneiige tweelingzwangerschappen werden gevolgd vanaf het eerste trimester 
van de zwangerschap tot aan de geboorte. Metingen van TTS en geen-TTS 
zwangerschappen werden met elkaar vergeleken, rekening houdend met de 
zwangerschapsduur. Alle patiënten werden geïnformeerd over de symptomen 
die kunnen optreden bij TTS, en werden geïnstrueerd om in het geval van 
snelle groei van de buik of premature contracties direct kontakt met ons op te 
nemen. In vier zwangerschappen ontwikkelde zich een TTS en in alle gevallen 
werd de diagnose tijdig gesteld. Ten tijde van de diagnose, was er éénmaal 
sprake van Quintero stadium 1, tweemaal Quintero stadium 2, en éénmaal 
Quintero stadium 3. Tweemaal werd de diagnose gesteld naar aanleiding van 
het feit dat de patiënte aangaf dat haar buik extreem snel gegroeid was. Bij 
echografisch onderzoek bleek één parameter voorspellend ten aanzien van 
het ontwikkelen van TTS: geïsoleerd polyhydramnion in één vruchtzak, zonder 
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oligohydramnion in de andere vruchtzak. Deze echobevinding was aanwezig 
in twee van de vier zwangerschappen voorafgaand aan het ontwikkelen van 
TTS. Alle andere echobevindingen voorafgaand aan de diagnose TTS waren 
niet verschillend van die in de groep waarin zich geen TTS ontwikkelde. 
Tweewekelijks echo-onderzoek, met speciale aandacht voor de beoordeling 
van de vruchtwatercompartimenten van beide kinderen, in combinatie met het 
geven van patiëntinstructies met betrekking tot het melden van symptomen 
die kunnen optreden bij TTS, resulteerde in het tijdig stellen van de diagnose 
in alle zwangerschappen waar zich TTS ontwikkelde en lijkt een veilig 
controlebeleid van monochoriale tweelingzwangerschappen. 
In Hoofdstuk 3 worden de resultaten beschreven van de eerste 100 TTS 
zwangerschappen die tussen augustus 2000 en november 2004 in het LUMC 
werden behandeld door middel van foetoscopische laser coagulatie van de 
vasculaire anastomosen. De mediane zwangerschapsduur bij behandeling 
was 20 weken en bij geboorte 33 weken. De perinatale overleving was 
70% (139/200). Behandeling resulteerde in 81% van de zwangerschappen 
in tenminste 1 overlevend kind op de leeftijd van 4 weken. De perinatale 
overleving was significant beter wanneer behandeling plaatsvond in de vroege 
Quintero stadia (95% in stadium 1, 76% in stadium 2, 70% in stadium 3 en 
50% in stadium 4). Onze behandelingsresultaten waren vergelijkbaar met die 
van gespecialiseerde centra in het buitenland. Onze bevindingen suggereren 
dat diagnose en behandeling van TTS in de vroege Quintero stadia tot betere 
perinatale overleving leidt.
In Hoofstuk 4 hebben wij onderzocht hoe vaak er in TTS placenta’s die 
met laser behandeld waren, nog sprake was van rest-anastomosen. Tevens 
bekeken wij de klinische gevolgen van deze rest-anastomosen. Wij vonden in 
33% (17/52) van de met laser behandelde placenta’s rest-anastomosen. De 
meeste rest-anastomosen (64%) waren extreem klein (diameter < 1mm). De 
aanwezigheid van rest-anastomosen was niet geassocieerd met een slechtere 
uitkomst (gedefinieerd als intrauteriene of neonatale sterfte, of ernstige 




grotere hemoglobine verschillen (> 5 g/dL) tussen de beide kinderen. Grote 
hemoglobine verschillen werden gedetecteerd in 65% (11/17) van de gevallen 
met rest-anastomosen vergeleken met 20% (7/35) van de gevallen zonder rest-
anastomosen (p < 0.01). Aldus hebben wij aangetoond dat 1/3 van de door ons 
met laser behandelde TTS placenta’s nog rest-anastomosen bevatten en dat 
deze rest-anastomosen vooral kunnen leiden tot hematologische complicaties.
Om de placenta en de daarop gelegen anastomosen optimaal in beeld te 
brengen, is het wenselijk om de foetoscoop onder een hoek van 90 graden 
ten opzichte van de placenta in de baarmoederholte in te brengen. Bij 
patiënten met een placenta op de achterwand van de baarmoeder is dit een 
relatief gemakkelijk te bereiken doel. Wanneer echter de placenta op de 
voorwand van de baarmoeder gelegen is, wordt het verkrijgen van optimale 
foetoscopische toegang technisch lastiger. In Hoofdstuk 5 beschrijven wij een 
nieuwe techniek voor foetoscopische entree bij patiënten met een placenta 
die de gehele voorwand van de baarmoeder bedekt. Onder laparoscopisch 
zicht, om schade aan de moederlijke darmen en bloedvaten in de buik te 
vermijden, wordt de foetoscoop door de laterale buikwand en vervolgens 
door de baarmoederachterwand in de baarmoederholte ingebracht. Op deze 
manier wordt onder optimale omstandigheden een hoek van bij benadering 
90 graden ten opzichte van de placenta verkregen. We vergeleken 16 TTS 
zwangerschappen met een complete voorwandplacenta, die behandeld 
werden volgens deze nieuwe operatietechniek (studiegroep) met 49 TTS 
zwangerschappen, die in dezelfde periode volgens de conventionele methode 
werden behandeld. In deze 49 zwangerschappen was 9 maal sprake van 
partiële voorwand placenta (controlegroep A) en 40 maal was er sprake van 
een laterale of achterwandplacenta (controlegroep B). We evalueerden het 
technisch resultaat van deze nieuwe procedure en de perinatale overleving. 
In de studiegroep kwam een procedure-gerelateerde complicatie in 25% 
(4/16) van de gevallen voor. Eenmaal bleek het onmogelijk de foetoscoop 
in de baarmoederholte in te brengen vanwege complexe intra-abdominale 
verklevingen. Driemaal ontstond na het inbrengen van de foetoscoop in 
de baarmoederholte een bloeding in het vruchtwatercompartiment (intra-
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amniotische bloeding), die het zicht op de placenta belemmerde waardoor 
geen complete laserbehandeling mogelijk was. Eén van deze patiënten moest 
een bloedtransfusie toegediend krijgen. De kans op procedure-gerelateerde 
complicaties in controlegroep A en B was respectievelijk 22% (2/9) en 5% 
(2/40). Deze complicaties bestonden uit: 3 maal een intra-amniotische 
bloeding en 1 maal ernstig vruchtwaterverlies in de moederlijke buikholte. De 
perinatale overleving in de studiegroep, controlegroep A and controlegroep B 
was respectievelijk 63% (20/32), 78% (14/18) and 70% (56/80). Laparoscopisch 
geleide foetoscopie is een nieuwe techniek die, bij TTS patiënten met 
een complete voorwandplacenta, veilige foetoscopische toegang tot de 
baarmoederholte en optimale visualisatie en coagulatie van de placentaire 
anastomosen mogelijk maakt. Het optreden van procedure-gerelateerde 
complicaties en perinatale overleving waren vergelijkbaar met de conventionele 
techniek. Procedure-gerelateerde complicaties komen wel vaker voor in geval 
van een placenta die geheel of deels over de voorwand van de baarmoeder ligt 
dan bij placenta lokalisatie op de laterale of achterwand van de baarmoeder.
In Hoofdstuk 6 beschrijven wij de lange termijn uitkomst bij TTS na laser 
behandeling. Alle kinderen met TTS die tussen 2000 en 2003 in het LUMC 
met laser behandeld zijn, werden geïncludeerd in deze studie. De perinatale 
mortaliteit betrof 70% (49/164). De neurologische status en de psychomotore 
ontwikkeling werden bepaald op de leeftijd van 2 jaar, gecorrigeerd voor de 
prematuriteit. Een abnormale psychomotore ontwikkeling werd gedefinieerd als 
één of meerdere van de volgende factoren: spasticiteit, doofheid, blindheid of 
een mentale of motorische ontwikkelingsindex van minder dan 70 (meer dan 
2 standaarddeviaties onder het gemiddelde). De incidentie van een abnormale 
psychomotore ontwikkeling was 17% (19/115) en was gebaseerd op spasticiteit 
(n = 8), doofheid (n= 1), achterstand in mentale ontwikkeling (n = 9) en 
achterstand in motorische ontwikkeling (n = 12). Wij concluderen dat kinderen 
met TTS ook na laser behandeling een hoge kans hebben op spasticiteit en 
ontwikkelingsachterstand en langdurige follow-up behoeven.




kinderen samen in één vruchtzak), waarbij één van beide kinderen ernstige 
aangeboren afwijkingen heeft, kan gekozen worden voor selectieve foeticide 
middels navelstrengcoagulatie. In dit geval blijft er voor het overlevende 
kind echter een risico bestaan op intrauterien overlijden als gevolg van 
navelstrengverstrengeling. In Hoofdstuk 7 beschrijven we 3 monoamniotische 
tweelingzwangerschappen, waarin sprake was van een ernstige aangeboren 
afwijking van één van beide kinderen (twee maal anencefalie en een maal een 
aangeboren hart blok). Op succesvolle wijze werd selectieve foeticide verricht 
middels foetosopisch dichtschroeien van de navelstreng (occlusie) met behulp 
van laser, gevolgd door doorsnijden (transsectie) van de navelstreng met 
behulp van kontakt laser. We beschrijven de technische details van de ingreep 
en de uitkomst van de drie zwangerschappen. De ingreep werd verricht bij 
een zwangerschapsduur van respectievelijk 15, 16 en 19 weken. In 1 casus 
ontstond vruchtwaterlekkage in aansluiting op de ingreeep. De overlevende 
kinderen werden geboren bij een zwangerschapsduur van respectievelijk 36, 38 
en 36 weken en waren gezond. In monoamniotische tweelingzwangerschappen, 
die gecompliceerd worden door één kind met een ernstige aangeboren 
afwijkingen, is selectieve foeticide middels laser occlusie en laser transsectie 
van de navelstreng een technisch haalbare ingreep, die kan leiden tot de bijna 
a terme geboorte van het gezonde kind. 
In Hoofdstuk 8 vergeleken we retrospectief de uitkomsten van 21 
TTS zwangerschappen, waarin de diagnose TTTS gesteld werd na een 
zwangerschapsduur van 26 weken, die behandeld werden in het LUMC 
tussen januari 1991 en februari 2006 middels ofwel amniodrainage ofwel 
laserbehandeling. Onderzocht werd de incidentie van slechte uitkomst 
(gedefinieerd als intrauteriene of neonatale sterfte, ernstige neonatale 
morbiditeit en/of ernstige cerebrale schade) en zwangerschapsduur bij de 
geboorte. Elf TTS zwangerschappen werden behandeld met amniodrainage en 
tien met laser. De mediane zwangerschapsduur bij de geboorte was 29 weken 
in de amniodrainage groep en 31 weken in de laser groep . Alle kinderen 
werden levend geboren. Er was geen significant verschil tussen beide groepen 
in ernstige cerebrale schade, neonatale sterfte of gecombineerde slechte 
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uitkomst. Ernstige neonatale morbiditeit kwam echter significant vaker voor in 
de amniodrainage groep dan in de laser groep, respectievelijk in 27% (6/22) en 
0% (0/20). Wij concluderen dat wanneer de diagnose TTS na 26 weken wordt 
gesteld, zowel amniodrainage als laser resulteerde in 100% overleving bij de 
geboorte. Echter, bij TTS kinderen behandeld met laser kwam minder ernstige 
neonatale morbiditeit voor. Onze bevindingen suggereren dat er een rol is voor 
laser behandeling, ook bij TTS gediagnostiseerd na 26 weken.
Samenvattend kunnen we stellen dat, hoewel er in het laatste decennium 
belangrijke vooruitgang is geboekt op het gebied van de foetoscopische foetale 
behandeling, te late verwijzing voor behandeling en perinatale complicaties 
nog frekwent voorkomen. Verder onderzoek op dit gebied ter verbetering 








AA   arterioarterial
AV  arteriovenous
BSID  Bayley scales of infant development
CP  cerebral palsy
DV  ductus venosus
DVP  deepest vertical pocket
EDF  end-diastolic flow
EFW  estimated fetal weight
Hb  haemoglobin
IUGR  intrauterine growth restriction
LUMC  Leiden University Medical Centre
MCA-PSV middle cerebral artery peak systolic velocity
MDI  mental development index
NDI  neurodevelopmental impairment
NND  neonatal death
PDI  psychomotor development index
PVl  periventricular leucomalacia
RA  residual anatomoses
TAPS  twin anaemia-polycythaemia sequence
TOPS  twin oligo-polyhydramnios sequence
TRAP  twin reversed arterial perfusion
TTTS  twin-to-twin transfusion syndrome
UA  umbilical artery








From the Division of Fetal medicine, Department of Obstetrics, Leiden 
University Medical Centre, Leiden:
Annemieke Middeldorp, Marieke Sueters, Dick Oepkes, Frans Klumper, Frank 
Vandenbussche, Humphrey Kanhai
From the Division of Neonatology, Department of Paediatrics, Leiden University 
Medical Centre, Leiden:
Enrico Lopriore, Frans Walther
From the Department of Gynaecology, Leiden University Medical Centre, Leiden: 
Frank Willem Jansen
From the Department of Surgery, Leiden University Medical Centre, Leiden:
Jan Ringers








Lopriore E, Middeldorp JM, Sueters M, Oepkes D, Vandenbussche FP, Walther FJ. Long-term 
neurodevelopmental outcome in twin-to-twin transfusion syndrome treated with fetoscopic 
laser surgery. American Journal of Obstetrics and Gynecology 2007; in press.
Middeldorp JM, Lopriore E, Sueters M, Jansen FW, Ringers J, Klumper FJ, Oepkes D, 
Vandenbussche FP. Laparoscopically guided uterine entry for fetoscopy in twin-to-twin 
transfusion syndrome with completely anterior placenta: a novel technique. Fetal Diagnosis 
and Therapy 2007; in press.
Lopriore E, Middeldorp JM, Oepkes D, Klumper FJ, Walther FJ, Vandenbussche FP. Residual 
anastomoses after fetoscopic laser surgery in twin-to-twin transfusion syndrome: frequency, 
associated risks and outcome. Placenta 2007;28:204-8.
Middeldorp JM, Sueters M, Lopriore E, Klumper FJ, Oepkes D, Devlieger R,
Kanhai HH, Vandenbussche FP. Fetoscopic laser surgery in 100 pregnancies with severe twin-
to-twin transfusion syndrome in the Netherlands. Fetal Diagnosis and Therapy 2007;22:190-
194.
Lopriore E, Middeldorp JM, Oepkes D, Kanhai HH, Walther FJ, Vandenbussche
FP. Twin anemia-polycythemia sequence in two monochorionic twin pairs without
oligo-polyhydramnios sequence. Placenta 2007;28:47-51.
Lopriore E, van den Wijngaard JP, Middeldorp JM, Oepkes D, Walther FJ, van
Gemert MJ, Vandenbussche FP. Assessment of feto-fetal transfusion flow through placental 
arterio-venous anastomoses in a unique case of twin-to-twin transfusion syndrome. Placenta 
2007;28:209-11.
van den Wijngaard JP, Lewi L, Lopriore E, Robyr R, Middeldorp JM,
Vandenbussche FP, Devlieger R, Deprest J, Ville Y, van Gemert MJ. Modeling severely 
discordant hematocrits and normal amniotic fluids after incomplete laser therapy in twin-to-
twin transfusion syndrome. Placenta 2006;[Epub ahead of print]
 
Sueters M, Middeldorp JM, Lopriore E, Oepkes D, Kanhai HH, Vandenbussche FP. Timely 
diagnosis of twin-to-twin transfusion syndrome in monochorionic twin
pregnancies by biweekly sonography combined with patient instruction to report
onset of symptoms. Ultrasound in Obstetrics and Gynecology 2006;28:659-64.
Adama van Scheltema PN, Feitsma AH, Middeldorp JM, Vandenbussche FP, Oepkes
D. Amnioinfusion to facilitate external cephalic version after initial failure.
Obstetrics and Gynecology 2006;108:591-2.
Lopriore E, van Wezel-Meijler G, Middeldorp JM, Sueters M, Vandenbussche FP,
Walther FJ. Neurodevelopmental outcome after laser therapy for twin-twin transfusion 
syndrome. American Journal of Obstetrics and Gynecology 2006;[Epub ahead of print]
Lopriore E, van Wezel-Meijler G, Middeldorp JM, Sueters M, Vandenbussche FP,
Walther FJ. Incidence, origin, and character of cerebral injury in twin-to-twin transfusion 
syndrome treated with fetoscopic laser surgery. American Journal of Obstetrics and 
Gynecology 2006;194:1215-20.
Lopriore E, Sueters M, Middeldorp JM, Klumper F, Oepkes D, Vandenbussche FP. Twin 
pregnancies with two separate placental masses can still be monochorionic
and have vascular anastomoses. American Journal of Obstetrics and Gynecology 
2006;194:804-8.
170
Middeldorp JM. Obesitas en zwangerschap. In: Kanhai HHH, Hoornweg J eds. Verloskundige 
zorg in de eerste lijn. Boerhaave commissie PAOG. Leiden 2005;107-13. ISBN 90-6767-584-9.
Lopriore E, Sueters M, Middeldorp JM, Oepkes D, Vandenbussche FP, Walther
FJ. Neonatal outcome in twin-to-twin transfusion syndrome treated with fetoscopic laser 
occlusion of vascular anastomoses. Journal of Pediatrics 2005;147:597-602.
Sueters M, Middeldorp JM, Oepkes D, Lopriore E, Vandenbussche FP. Twin-to-twin transfusion 
syndrome at 11 weeks of gestation. Am J Obstet Gynecol 2005;193:887-8.
Lopriore E, Sueters M, Middeldorp JM, Vandenbussche FP, Walther FJ. Haemoglobin differences 
at birth in monochorionic twins without chronic twin-to-twin transfusion syndrome. Prenatal 
Diagnosis 2005;25:844-50.
Middeldorp JM, Lopriore E, Vandenbussche FP. Foetoscopische lasercoagulatie van placentaire 
anastomosen als behandeling van het tweelingtransfusie syndroom. Nederlands Tijschrift voor 
Kindergeneeskunde 2005;73:125-31. 
Middeldorp JM, Sueters M, Klumper FJ, Oepkes D, Lopriore E, Kanhai HH, Vandenbussche FP. 
Foeoscopische laserbehandeling in Nederland. In: Vandenbussche FPHA, Kanhai HHH, Walther 
FJ eds. Vorderingen in de foetale geneeskunde. Boerhaave commissie PAOG. Leiden 2005;95-
9. ISBN 90-6767-571-7.
Witsenburg CP, Rosendaal FR, Middeldorp JM, Van der Meer FJ, Scherjon SA.  Factor VIII levels 
and the risk of pre-eclampsia, HELLP syndrome, pregnancy related hypertension and severe 
intrauterine growth retardation.Thrombosis Research 2005;115:387-92. 
Lopriore E, Middeldorp JM, Sueters M, Vandenbussche FP, Walther FJ. Twin-to-twin transfusion 
syndrome: from placental anastomoses to long-term neurodevelopmental outcome. Current 
Pediatric Reviews 2005;3:191-203.
Middeldorp JM, Klumper FJ, Oepkes D, Lopriore E, Kanhai HH, Vandenbussche
FP. Eerste resultaten in Nederland van foetoscopische laserbehandeling bij 
tweelingtransfusiesyndroom in het tweede trimester van de zwangerschap vergelijkbaar met 
internationale resultaten. Nederlands Tijdschrift voor Geneeskunde 2004;148:1203-8.
Feitsma AH, Middeldorp JM. Haemorrhagia post partum: ballonnetje opblazen of oplaten. 
Nederlands Tijdschrift voor Obstetrie en Gynaecologie 2004;117:129-130.
Oepkes D, Middeldorp JM, Nijhuis JG, Knahai HH, Creemers JWT. Managing obstetric 
emergencies and trauma (MOET): een nieuwe cursus voor gynaecologen. Nederlands 
Tijdschrift voor Obstetrie en Gynaecologie 2004;117:62-4.
Middeldorp JM, Klumper F, Vandenbussche FP. Tweede trimester tweelingtransfusie syndroom. 
Tijdschrift voor Verloskundigen 2003;3:126-9.
Middeldorp JM. Kraamvrouwenkoorts. In: Springer MP ed. Verloskunde voor de huisarts. 
Boerhaave commissie PAOG. Leiden 2001;91-6. ISBN 90-6767-491-5.
Middeldorp JM. Bloedverlies in de zwangerschap. Modern Medicin 2000;24:826-30.
Bax A, Middeldorp AM, Harinck B, Holleboom C, van Roosmalen J. Unilateral pulmonary edema 
as a life-threatening complication of ritodrine. Acta Obstetricia et Gynecologica Scandinavica 
1999;78:915-6.
Middeldorp JM. Totaalruptuur en bekkenbodemschade: prevalentie en preventie. In: Springer 
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maar was daarom juist onmisbaar.
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Nicolette, als assistent samen visite gelopen met de baas, allebei een beetje 
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